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ABSTRACT 
 
 
Glial-cell-line-derived neurotrophic factor (GDNF) signaling through the receptor 
tyrosine kinase Ret and its co-receptor Gfr?1 is indispensable for the ureteric bud (UB) 
outgrowth. Several GDNF regulated genes have been identified, but the early responsive 
genes in UB formation have remained largely unknown. 
To search for novel genes regulated by GDNF in the ureteric bud epithelium, we 
performed a genome wide analysis of Wolffian ducts induced by GDNF in vitro, and 
identified 69 up-regulated genes.  
The specificity of the highly up-regulated genes expression to the ureteric epithelium 
and the absence of these genes from the Gdnf- null allele kidneys were among the criteria 
for validation of the microarray data. Plakophilin2 gene encoding for the armadillo 
protein- Pkp2 and Visinin-like 1 gene, encoding for a neuronal calcium sensor protein- 
VSNL1 fulfilled these criteria and were chosen for further analysis. 
Analysis  of  the  Pkp2- null allele kidneys revealed a defect in ureteric branching, as 
Pkp2-/- kidney explants did not undergo UB branching in vitro, but responded to GDNF by 
producing supernumerary buds. This suggests that Pkp2 is not crucial for UB formation 
from the WD per se.  However,  the  high  embryonic  lethality  of  Pkp2- null allele mice 
might cause secondary damage in the dissected kidney rudiments, not only disrupting the 
UBs, but also the metanephric mesenchyme.   
VSNL1 characterized the tip domain of the UB epithelium regardless of the inducer 
and  its  levels  of  expression  correlated  with  the  degree  of  ureteric  branching.  In  the  UB  
tips, VSNL1 displayed a unique mosaic expression pattern that could be correlated neither 
with Ret activity nor with the cell cycle progression. This demonstrates the existence of 
heterogeneity of cell types in the tip domain that might be critical for normal ureteric 
branching. However, we have identified that VSNL1 expression was mutually exclusive 
with ?-catenin transcriptional activation, and it was downregulated in both, ?-catenin 
stabilized and ?-catenin deficient kidneys. Moreover, in vitro, VSNL1 compromised  
?-catenin stability. This suggests an antagonistic effect between VSNL1 and ?-catenin.  
To provide a step forward in understanding the possible function of Vsnl1 during 
development, Vsnl1 spatial and temporal expression during mouse embryogenesis was 
further addressed. Vsnl1 mRNA and protein were detected in all embryonic derivatives of 
the intermediate mesoderm.  
Interestingly, in early development, Vsnl1 was specifically confined to the cardiac 
anlagen, derived from the lateral plate mesoderm. All myocardial cells that contributed to 
the remodeling of the venous pole of the heart were positive for Vsnl1. Therefore, Vsnl1 
might be used as a specific marker for cell lineages tracing during cardiac embryogenesis. 
An expansion of the VSNL1 expression domain to the ventricles was observed soon after 
the first week of postnatal life, and this pattern was maintained into adulthood.  
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The function of PlexinB2 during renal development was next addressed by analyzing 
the kidney phenotype in Plxnb2- null allele mice. Plexins (Plxn) constitute the main 
receptors of semaphorins (Sema), which were originally described as axon guidance cues. 
Plxnb2-/- embryos displayed hypoplastic kidneys, and occasional unilateral double kidneys 
and ureters. The defect in branching was intrinsic to the epithelium, as the isolated ureteric 
epithelium  grown  in  three-dimensional  culture  failed  to  respond  to  GDNF.  By  
coimmunoprecipitation experiments, PlexinB2 was found to interact with Ret, the GDNF 
receptor, suggesting that PlexinB2 activated by Sema4C ligand modulates ureteric 
branching, possibly by a direct regulation of Ret activity. 
Taken together, this thesis identified two novel early responsive genes to GDNF in the 
ureteric epithelium, Pkp2 and Vsnl1, which might bring insights in elucidating the 
mechanisms of UB outgrowth and branching morphogenesis. It also revealed that Vsnl1 
becomes first evident in the cardiac anlagen during mouse embryogenesis and it is 
confined to the cardiac myocardium at the venous pole of the embryonic heart. Finally, 
this study also provides evidence that Sema4C/PlexinB2 signaling modulates kidney 
branching morphogenesis, putatively through direct cross-talk with GDNF/Ret signaling. 
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1 REVIEW OF THE LITERATURE  
 
The embryonic epiblast, containing all the progenitor cells that generate the future 
embryo, gives rise to mesoderm, the middle embryonic germ layer. Following 
gastrulation, the mesodermal germ layer forms all the organs between ectoderm and 
endodermal tissues and plays a fundamental role in organizing the vertebrate body axis.  
This literature review focuses mainly on the development of two mesodermal derived 
organs, the kidney and the heart, which are formed from distinct progenitors, the 
intermediate mesoderm (IM) and the lateral plate mesoderm (LPM), respectively. 
 
1.1 MESODERM  INDUCTION AND PATTERNING 
 
Mesodermal precursors, formed in the primitive streak, migrate and give rise along the 
medio-lateral axis to distinct populations including axial mesoderm (precursors of the 
notochord and head mesoderm), paraxial mesoderm (PM) (future somites), IM (precursors 
of  the  urogenital  system),  LPM  (including  the  somatic  precursors  of  the  body  wall  and  
limbs, and the splanchnic- precursors of cardiovascular system and gut lining mesoderm), 
and the extraembryonic mesoderm (EEM) which forms the umbilical cord (Gilbert, 2010). 
The subdivision of the early mesoderm into its domains is specified by a bone 
morphogenetic protein (BMP) signaling gradient, which increases from the midline of the 
embryo, laterally (Tonegawa et al., 1997). It is thought that the BMP gradient determines 
differential expression of Forkhead/winged helix (Fox) transcription factors. Foxc 
determines the cephalic, PM and IM (Wilm et al., 2004), while the Foxf specifies the LPM 
and EEM (Mahlapuu et al., 2001; Carlsson and Mahlapuu, 2002).  
 
1.1.1 IM Gives Rise to Urogenital Tissues 
 
Tissue culture experiments in chicken have shown that the IM is specified to form the 
urogenital system by interactions with the adjacent paraxial mesoderm (Mauch et al., 
2000). These interactions induce the expression of the early transcription factors Osr1, 
Lim1, Pax2, and Pax8 in the IM, which is now patterned along the anterior-posterior axis 
and forms the primary nephric duct (ND), also called the Wolffian duct (WD) (Bouchard 
et al., 2002; Kobayashi et al., 2005; Wang et al., 2005; James et al., 2006). 
FoxC1 and  FoxC2  play  roles  in  the  establishment  of  the  IM.  In  Foxc1 and Foxc2 
double null allele mice, the PM turns into IM, expressing the early trascription factor Pax2 
(Wilm et al., 2004). In both chicken and Xenopus,  BMP4  from  the  ectoderm  is  also  
required for the duct formation (James and Schultheiss, 2005; Bracken et al., 2008). Lim1 
induces the expression of Pax2 in a reversible manner and is essential for converting the 
IM into the WD and later on, for ureteric bud (UB) formation and for nephrogenesis. All 
these factors together with ?-catenin are required for the expression of Gata3 transcription 
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factor (Grote et al., 2006). Gata3 and ?-catenin induce the expression of receptor tyrosine 
kinase Ret in the ND (Bridgewater et al., 2008; Grote et al., 2008). 
 
1.1.2 LPM Specification 
 
The LPM is subdivided into somatic and splanchnic (visceral) mesoderm giving rise to 
the body cavity (coelom), which further divides into pleural, pericardial and peritoneal 
cavities (Funayama et al., 1999).  
The cardiovascular system consisting of heart, blood cells and blood vessels, is derived 
from the splanchnic LPM and is the first functional unit to develop in the vertebrate 
embryo.  
Cells are specified, but not determined to a myocardial fate, until after their ingression 
into the primitive streak and migration into the LPM, in response to signals from 
surrounding tissues. Interactions of the cranial lateral mesoderm with the endoderm is 
required for cardiac specification (Abu-Issa and Kirby, 2007). 
Mesp1/2 (mesoderm posterior 1 and 2 homolog) regulated by fibroblast growth factors 
(FGFs), and Fgf8 are the earliest indicators of cardiogenic mesoderm, and the proteins are 
required for the cardiac progenitors cells ingression during gastrulation and for the cardiac 
mesoderm specification (Saga et al., 2000; Ilagan et al., 2006). BMP from the lateral 
mesoderm and endoderm induces Fgf8 in the endoderm (Alsan and Schultheiss, 2002), 
and together with Wnt antagonists specify the cardiac mesoderm (Marvin et al., 2001). 
Inhibitory signals from the notochord including Noggin and Chordin, two molecules that 
sequester BMPs, and the Wnt ligands (Wnt1 and Wnt3a) from the neural tube that also 
antagonize BMP signals, restrict the splanchnic mesoderm domain (Abu-Issa and Kirby, 
2007). 
 
1.2 DEVELOPMENT OF THE KIDNEY 
 
1.2.1 Development of the Metanephric Kidney  
 
Development of the kidney in mammals progresses through three spatially and 
temporally distinct stages: pronephros, mesonephros and metanephros. The first two 
stages are transient structures in mammalians and do not contribute to the formation of the 
mature kidney, but they play major roles in the development of the gonads, adrenal gland 
and hematopoetic precursors. The third stage, the metanephros persists and gives rise to 
the functional kidneys (Figure 1). 
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Figure 1. The murine IM derivatives in 
antero-posterior arrangement. (A) The 
pro-nephric duct forms at E9.0 in mouse 
and induces epithelial tubules from the 
adjacent mesenchyme. (B) The nephric 
duct reaches the cloaca at E10 and induces 
mesonephric tubules; (C) By E10.5, the 
UB pounches out from the duct and 
invades the metanephric mesenchyme. (D) 
By E11, the UB has branched and induced 
the cap mesenchyme. Modified from 
(Dressler, 2009) 
 
The  IM contains  the  precursors  of  all  three  types  of  kidneys.  Initially,  mesenchymal  
cells from dorsal IM migrate caudally, and differentiate to epithelial cells of the WD 
(Saxen and Sariola, 1987), which subsequently elongates by caudal extension, until it 
reaches and connects to the cloaca (Figure 1). The mesenchymal cells from the ventral IM, 
called the “nephrogenic cord”, remain in an undifferentiated state until later in 
development. The interaction between the WD and the adjacent nephrogenic cord induces 
the formation of the initial renal tubules, the pronephros. In mice, this induction takes 
place at E9 (Figure 1A). By E10, the middle part of the nephric duct induces the 
mesonephric mesenchyme to form a new set of kidney tubules along the WD, which 
constitute the mesonephros (Saxen and Sariola, 1987) (Figure 1B). Finally, the 
metanephros, the permanent and functional mammalian kidney develops more caudally, 
close to the cloaca, at E10.5 in mouse and E30 in humans (Figure 1C). The metanephros is 
generated through a complex set of reciprocal inductive interactions between the two IM 
derived tissues: the metanephric mesenchyme (MM) and the WD-derived UB (Figure 1D). 
  
1.2.2 Specification of the Metanephric Mesenchyme  
 
The MM is unique in the way that, it is the only tissue competent to produce nephrons 
in response to inductive signals from the UB (Saxen, 1970; Sariola et al., 1982). In 
addition, the MM promotes the UB outgrowth from the WD, which undergoes several 
cycles of branching, giving rise to the collecting duct system. The MM is specified by 
transcription factors including the Hox11 paralogue group, Wilms’ Tumor gene 1 (WT1), 
Eya1 and Pax2,  which  all  act  in  the  MM  to  induce  the  expression  of  Glial  cell-derived  
neurotrophic factor (Gdnf) and Six2 (Kreidberg et al., 1993; Gong et al., 2007). GDNF 
signaling is the main regulator of ureteric budding and branching morphogenesis, whereas 
Six2 is required for MM cell renewal (Self et al., 2006; Kobayashi et al., 2008). 
 
1.2.3 Inductive Interactions in the Kidney Development 
 
Iniatially, the MM induces the formation of the UB, as a single epithelial outgrowth 
from the WD, near its caudal end. The UB invades the adjacent MM according to the 
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inductive signals provided by the same mesenchyme and branches for the first time giving 
rise to a T-shaped bud, around day E11 in mouse.  
The UB consists in two distinct cell populations: the tip cells and the stalk (trunk) 
cells. Each of this will be discussed in more detail in Section 1.2.8. 
Reciprocally, the tips of the new UBs induce the cap mesenchyme, a subpopulation of 
cells within the MM surrounding the UB, to undergo mesenchymal to epithelium 
transition (MET) to form the pretubular aggregates at the armpits of the T-bud. The cap 
condensate expresses Six2, Gdnf and Cited1, and is surrounded by stromal mesenchyme 
expressing Foxd1 transcription factor and retinoic acid receptors (RAR). These aggregates 
form renal vesicles expressing Wnt4 and Pax8, induced by the canonical Wnt9b from the 
ureteric epithelium (Costantini and Kopan, 2010).  
The pretubular aggregates containing about 20 proliferating cells elongate and give rise 
to ‘Comma’ and S-shape nephrogenic bodies. These epithelial structures will differentiate 
subsequently into regionally specific cell types of secretory nephrons, the capsule cells, 
the podocytes and the proximal and distal tubules, forming the functional units of the 
kidney (Saxen and Sariola, 1987). The UBs remain connected to the newly formed 
tubules, allowing urine to pass from one into another (Bard et al., 2001). 
The reciprocal signaling between the UB and MM continues in mice until the first 
postnatal days, and the ureteric epithelium undergoes repeated cycles of bifurcated 
branching to form a highly arborated collecting ductal (CD) system, which drains the urine 
to urethra. Simultaneously, the tips of the branches continue inducing more nephrons, up 
to the point, when the last competent mesenchymal cells have been induced. There is a 
great variability in the number of the nephrons in the mature kidneys between species. In 
the mouse, there are about 15.000 nephrons, and in humans there are approximately 1 
million (Nyengaard and Bendtsen, 1992). The pattern of ureteric branching determines the 
shape and the size of the kidney, and the number of nephrons depends on the number of 
UB branch points.  
In addition to the mesenchymal and UB derived epithelial cells, other cells types 
participate in the formation of the kidney including vascular, stromal, and smooth muscle 
cells (al-Awqati and Goldberg, 1998).  
 
1.2.4 GDNF/GFR?/Ret Signaling  
 
GDNF signaling takes place through a tetrameric receptor complex, which includes 
two glycosylphosphatidylinositol (GPI)- anchored GDNF family receptor (GFR?) 
molecules and two Ret (rearranged during transfection) receptor tyrosine kinases (Jing et 
al., 1996). The binding of GDNF, activates distinct intracellular pathways (Sariola and 
Saarma, 2003) (Figure 2).  
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Figure 2. GDNF/Gfr?1/Ret complex.  
GDNF dimer binds to 2 molecules of GFR? and 
triggers two Ret receptor tyrosine kinases, which 
activates downstream signaling. Modified from 
(Sariola and Saarma, 2003). 
 
GDNF belongs to Glial cell line-
derived neurotrophic factor (GDNF) family 
ligands (GFLs), along with other members: 
neurturin (NRTN), artemin (ARTN), and 
persephin (PSPN) (Airaksinen et al., 1999). GDNF was discovered to promote the survival 
of midbrain dopaminergic neurons in vitro (Lin et al., 1993), suggesting a potential role in 
Parkinson’s disease (PD). Outside of nervous system, GDNF regulates kidney 
morphogenesis and spermatogonial differentiation (Airaksinen et al., 1999; Sariola and 
Saarma, 2003). 
Ret proto-oncogene encodes a transmembrane receptor of the tyrosine kinase (RTK) 
superfamily of proteins. Ret protein structure is very similar to that of other RTKs (Figure 
3), but the extracellular domain is exceptional, as it consists of four cadherin-like domains 
(CLDs) and one binding sites for Ca2+ between  each  of  these  domains  (Anders  et  al.,  
2001). Ca2+ ions  are  important  for  the  correct  folding  of  Ret,  Ret  dimerization,  and  for  
binding to GDNF and its activation (van Weering and Bos, 1997; Nozaki et al., 1998; 
Anders et al., 2001). 
 
Figure 3. Structure of the receptor tyrosine kinase Ret. The 
extracellular domain consists of 4 cadherin-like domains, 3 Ca2+ 
binding sites and a cysteine-rich region. The transmembrane region 
consists in a single plasma membrane-spanning region, and the 
intracellular domain contains a large, intercalated tyrosine kinase 
domain. 
 
Besides of its important role in kidney morphogenesis, 
Ret is critical for the development of the enteric nervous 
system (ENS) (Schuchardt et al., 1994; Schuchardt et al., 
1996) and neoplasia. Accordingly, c-RET mutations in 
humans lead to Hirschsprung’s disease, (HSCR) (Attie et 
al., 1996), multiple endocrine neoplasia (MEN) types 2A 
and 2B and familial medullary thyroid carcinoma 
(FMTC) (Jhiang, 2000; Smith-Hicks et al., 2000). Due to 
alternative splicing, Ret exists in three different isoforms, 
which differ in their length by having 51, 43, and 9 amino 
acids in the C-terminus. They have been named 
accordingly  as  Ret51-  long,  Ret43-  intermediate,  and  Ret9-  short  isoform.  The  first  and  
the last are the major isoforms (Arighi et al., 2005). 
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1.2.5 GDNF/Ret Signaling in Kidney Morphogenesis 
 
GDNF signaling is indispensable for the kidney development, as the kidneys fail to 
form  in  the  mouse  mutants  deficient  for  Gdnf, Ret and Gfr?1 (Schuchardt et al., 1994; 
Sanchez et al., 1996; Schuchardt et al., 1996; Enomoto et al., 1998). Also in humans, renal 
agenesis is often associated with high rate RET mutations (Skinner et al., 2008). 
GDNF is secreted from the MM, while both receptors are expressed along the WD, 
prior to ureteric budding and become restricted to the newly formed UB tips (Sainio et al., 
1997). Deletion of mouse Ret9 and Ret51 isoforms, revealed distinct functions. The 
expression of murine Ret9 isoform is sufficient for normal development of excretory 
system (de Graaff et al., 2001). However, later studies show that either of the human RET 
isoforms is enough to support normal kidney development, suggesting differences in the 
properties of the human and chimeric murine Ret51 (Jain et al., 2006). 
Several in vitro and genetic studies in mice indicate that GDNF promotes UB cell 
proliferation and survival (Sainio et al., 1997; Towers et al., 1998; Michael and Davies, 
2004; Shakya et al., 2005; Fazzari et al., 2007), as well as cell migration (Chi et al., 2009). 
GDNF acts as a ramogen, inducing branching of the UB, but also as a morphogen, 
controlling the growth of the UB tips in specific directions. Its localized expression in the 
posterior region of the caudal WD is important for promoting the outgrowth of a single, 
correctly placed ureter. However, the localized expression of GDNF is not critical for 
patterning the growth of the UB, since the missexpression of Gdnf in the ureteric 
epithelium, in the absence of methanepric Gdnf had only minor effects on kidney 
development. Gdnf expression, as well as GDNF/Ret signaling are regulated by positive 
and negative modifiers, which determine the precise positioning of the UB outgrowth, the 
number of the UBs, as well as the subsequent branching morphogenesis of the ureteric 
epithelium. Several of these positive regulators, when deleted, cause renal agenesis. In 
addition to Pax2, Gata3, and Hox11 paralogue group (Gong et al., 2007), which are the 
transcriptional activators of Gdnf in the MM, other transcription factors such as Eya1 
(Sajithlal et al., 2005), Six2 (Brodbeck et al., 2004) and Sall1 (Nishinakamura et al., 
2001), and upstream signaling molecules (Npnt, ???1 integrin, Gdf-11 and Neuropeptide 
Y), are required for the localization and normal activity of GDNF signaling (Boyle and de 
Caestecker, 2006; Costantini and Kopan, 2010). 
Different negative signals regulated by the FoxC1/2 transcription factors (Kume et al., 
2000), and the transmembrane protein Slit2 (slit homolog 2) and its receptor Robo2 (round 
about homolog 2) restrict the spatial Gdnf expression in the posterior MM from extending 
rostrally, and thereby define the area of the UB outgrowth (Grieshammer et al., 2004). 
Spry-1 (Sprouty homolog 1), an inhibitor of the RTK signaling, negatively regulates the 
response to GDNF and thus limits GDNF signaling, so that kidney induction is restricted 
to a single site (Chi et al., 2004; Basson et al., 2005). In the absence of these regulators, 
numerous ureteric buds are formed along the WD (Kume et al., 2000; Chi et al., 2004; 
Grieshammer et al., 2004; Basson et al., 2005). Also BMP4 expressed by the 
mesenchymal cells in the close proximity to WD, displays an inhibitory effect on GDNF 
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signaling (Miyazaki et al., 2000). However, in the posterior MM, Gremlin1, a BMP4 
antagonist, inhibits BMP signaling, and therefore de-represses GDNF activity in this 
region (Michos et al., 2007). 
 
1.2.6 Signaling Independent of GDNF 
 
For many years, GDNF signaling was considered as both necessary and sufficient for 
UB formation.  However, a substantial number of mice lacking Gdnf (27%) or its receptor, 
Ret (40 to 45%) show rudimentary kidneys, suggesting that pathways partially redundant 
to GDNF contribute to ureteric budding (Schuchardt et al., 1994; Moore et al., 1996). 
Recently, both in vitro and in vivo studies have revealed roles for members of FGF family 
in primary ureteric budding. In organ cultures, FGF7 promotes supernumerary UBs from 
the WD, but only in the presence of Follistatin, an inhibitor of Activin A (Maeshima et al., 
2007). Moreover, FGF10 alone, has the same effect (Michos et al., 2010).  
Mice depleted of either Fgf7 or Fgf10 in the MM, (Qiao et  al.,  1999b; Ohuchi et  al.,  
2000), or Fgfr2 in the ureteric epithelium display hypoplastic kidneys (Zhao et al., 2004), 
a renal defect far less severe than in mice lacking Gdnf or Ret,  indicating  that  FGF  
signaling plays only, a secondary role in vivo. FGF10 can substitute many renal functions 
of GDNF signaling through Ret, but only in the absence of Spry1, suggesting that 
additional signals are required for normal ureteric budding (Michos et al., 2010). 
 
1.2.7 UB Branching and Growth 
 
After the first UB is formed and invades the mesenchyme, the UB undergoes about 10 
cycles of orthogonal dichotomous branchings, followed by CD elongation, and then 
another two-three rounds of branchings in the renal cortex (Cebrian et al., 2004). 
Several factors that act in a concert to induce the UB outgrowth from the WD (GDNF, 
FGFs and BMP4), are also involved in controlling the UB branching in the developing 
kidney. However, additional factors that promote branching morphogenesis have been 
identified, including retinoic acid (RA) receptors, Wnt11, pleiotrophin, vascular 
endothelial  growth  factor  A  (VEGF-A),  hepatocyte  growth  factor  (HGF),  and  the  
epidermal growth factor (EGF) (Costantini and Kopan, 2010). 
Negative  signals  from  the  MM  or  stroma,  including  TGF?2,  BMP4  and  BMP7  play  
regulatory roles in inhibiting branching morphogenesis (Dudley et al., 1995; Miyazaki et 
al., 2000; Sims-Lucas et al., 2008). Also, semaphorins negatively regulate branching 
morphogenesis. Deletions of Sema3a and Plxnb1, the receptor of Sema4D in the kidney, 
permits a transient increase in UB branching (Korostylev et al., 2008; Tufro et al., 2008). 
The  UB  epithelium  has  an  intrinsic  capacity  to  form  branches  and  to  elongate,  as  
branching can occur also in the absence of mesenchyme in vitro (Qiao et al., 1999a). 
However, the MM is important for the correct pattern of kidney branching (Sweeney et al., 
2008). 
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1.2.8 Tip versus Stalk 
 
The UB contains a heterogenous cell population, which differ in Ret activity as shown 
by chimeric cell lineage analysis and labeling of the UB cells with a Ret activity marker 
(Shakya et al., 2005; Chi et al., 2009). The UB tip cells display the highest Ret activity 
suggesting that Ret signaling is required for establishing the ureteric bud tip identity. 
The two regions within the UB differ in their proliferation rates, but also in gene 
expression patterns. Tip cells proliferate more rapidly during the branching cycles in order 
to form the ‘armpits’, while the stalk cells proliferate to elongate the collecting ducts. 
During cell division, some tip cells remain in the tip domain and self-renew, while other 
cells contribute mainly to stalk regions (Shakya et al., 2005). However, in vitro 
experiments have suggested that trunk cells can also form tip cells, when induced by MM 
(Sweeney et al., 2008). 
The tips of the UBs express a unique complement of markers, different from stalk 
regions, some of which are direct mediators of branching. In addition to the expression of 
GDNF receptors, Ret and Gfr?1, other markers such as Wnt11, Sox9, Ros1, Clf-1, Cxcl14, 
timeless, and Spry1 specify the tip domain (Pachnis et al., 1993; Kispert et al., 1996; 
Pepicelli et al., 1997; Majumdar et al., 2003; Schmidt-Ott et al., 2005; Basson et al., 
2006). The trunk cells, on the other hand, express markers such as Wnt7b, Wnt9b, the 
water channel Aquaporin2 and Aquaporin3, urea transporter Slc14a2, collagen XVIII, and 
are capable of binding of the lectin Dolichos biflorus agglutinin (DBA) (Bridgewater and 
Rosenblum, 2009). 
 
1.2.9 Signaling downstream of GDNF/Ret  
 
Several factors regulating GDNF and Ret have been identified, however only a few 
downstream genes are known. For example Ret, Wnt11 and Spry1. Wnt11 displays similar 
expression with Ret and Gfr?1 during renal development, and Wnt11 acts in a positive 
feedback loop for GDNF/Ret signaling (Pepicelli et al., 1997; Majumdar et al., 2003). 
Spry1 is induced specifically in the tips of the UB by GDNF/Ret signaling and acts in a 
negative loop to modulate Ret activity (Basson et al., 2006). Recently, more downstream 
regulated genes have been identified, those encoding for the chemokine receptor Cxcr4, 
the  cytokine  Crlf1  and  the  Etv4/Etv5  transcription  factors,  as  well  as  Dusp6 and Spred2 
signaling inhibitors. The expression of Etv4 and Etv5 is upregulated in the ureteric 
epithelium by GDNF/Ret signaling via PI3K/AKT, and mice depleted of Etv4-/-Etv5-/- 
display renal agenesis (Lu et al., 2009). 
Ret activation results in phosphorylation of key docking tyrosines that bind to several 
adaptor proteins and activate downstream signal transduction pathways such as Raf/Ras 
(Src), PKC (PLC?), PI3K/AKT, and Erk/MAPK (Shc and Grb2) (Airaksinen and Saarma, 
2002). In vivo amino acid substitution of tyrosine at the position 1062 in Ret tyrosine 
kinase (TK) domain, blocks both AKT and MAPK pathways and severely disrupt ureteric 
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branching (Jijiwa et al., 2004; Wong et al., 2005). Similar results have been obtained by in 
vitro inhibition of MAPK pathway (Fisher et al., 2001; Watanabe and Costantini, 2004). 
In vitro inhibition of the PLC? pathway and the kidney defects observed in PLC?1 null 
chimeras, suggest that Ret signaling through PLC? is necessary for the outgrowth of a 
single UB and also for patterning the branching morphogenesis (Shirane et al., 2001; Jain 
et al., 2006). Moreover, the kidney phenotype in Ret Y1015 mutation mice is remarkably 
similar to that of Spry1 null allele mice, suggesting a possible regulation of Sprouty 
signaling through Ret (Y1015) mediated PLC? activation (Jain et al., 2006). 
 
1.2.10  Wnt Signaling in Branching Morphogenesis 
 
Wnt signaling regulates cell functions by activating the canonical ?-catenin pathway, 
the planar cell polarity pathway, or the calcium pathway. The canonical Wnt pathway 
activates Dishevelled (Dsh) and subsequently inhibits glycogen synthase kinase-3? 
(GSK3?), which is a key event in the activation of the pathway that prevents the 
degradation of ?-catenin. Consequently, ?-catenin is translocated into the nucleus, where 
interacts with Lef/Tcf transcription factors to regulate Wnt target genes (Clevers, 2006). 
Several Wnt molecules are expressed and function in kidney morphogenesis. The 
ureteric epithelium expresses Wnt6 (Itaranta et al., 2002), Wnt9b (Carroll et al., 2005), 
Wnt7b (Yu et al., 2009) and Wnt11 genes (Majumdar et al., 2003), while Wnt4 is 
expressed by the MM (Kispert et al., 1998), and Wnt2b is specific to cortical stroma (Lin 
et al., 2001). Wnt4- and Wnt9b- null allele mice display defects in nephrogenesis (Stark et 
al., 1994; Kispert et al., 1998; Carroll et al., 2005), and deficiency of Wnt9b also disrupts 
branching morphogenesis (Karner et al., 2009). Mice deficient for Wnt7b indicate a 
potential role of the protein in collecting duct maintenance (Yu et al., 2009) and Wnt2b 
has been suggested to sustain branching morphogenesis (Lin et al., 2001).  Both, deletion 
and  activation  of  ?-catenin in the ureteric epithelium results in renal agenesis or 
hypodyplasia, and it has been suggested that ?-catenin acts upstream of genes required for 
ureteric branching morphogenesis (Bridgewater et al., 2008; Marose et al., 2008; 
Bridgewater et al., 2011). 
 
1.3 HEART DEVELOPMENT 
 
Early cardiac development involves the fusion of the bilaterally symmetric cardiogenic 
fields, derived from the splachnic mesoderm, into a cardiac crescent. The primary single 
heart tube, located in the midline of the body axis, underlying the head folds, represents 
the first heart field (FHF), which consists of an outer myocardial mantle, lined by 
endothelial cell layers (Stalsberg and DeHaan, 1969). 
By E8.5 in the mouse, the linear heart tube becomes centrally positioned in an anterior-
posterior (A/P) arrangement, and elongates by addition of the second heart field (SHF) 
cells to the poles and dorsal mesocardium, taking the shape of an inverted Y (Buckingham 
et al., 2005). 
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Each of the cardiac fields contributes to distinct cardiac regions (Figure 4). The FHF 
gives rise mostly to the left ventricle (LV). Unlike the FHF, the SHF cells remain 
undifferentiated until they migrate into the cardiac region. The anterior part of the SHF is 
programmed to make the outflow tract (OT) and right ventriculum myocardium (RV), and 
the posterior part of the SHF contribute to atrial myocardium (Zaffran et al., 2004; Galli et 
al.,  2008).  More  caudally,  the  two  arms  of  the  Y  are  continuous  with  the  developing  
venous tributaries of the embryo, yolk sac, and placenta, which will drain to either side of 
the common atrium through the right and left sinus venosus horns. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Early steps in heart development. 
Ventral view of the heart development. In the cardiac crescent, two domains of mesoderm progenitors, the 
first heart field (FHF) and second heart field (SHF) contribute to distinct cardiac regions. The FHF 
contributes to the development of the left ventricle (LV), while SHF contributes to the right ventricle (RV) 
and later to the outflow tract (OT); (SV) sinus venosus. A, atrium; V, ventricle. Modified from (Bruneau, 
2008). 
 
In addition to splanchnic mesoderm, three populations of extracardiac cells are 
incorporated into the heart through waves of cell migration (Savolainen et al., 2009). Cells 
from pro-epicardium, near the venous pole of the heart give rise to the epicardial 
epithelium covering the heart (Manner et al., 2001). The epicardial cells contribute to 
smooth muscle cells of the coronary vessels, cardiac fibroblasts, and to a subset of 
cardiomyocytes, which express WT1 and Tbx18 and are later found in all four chambers of 
the heart (Cai et al., 2008; Zhou et al., 2008a). Dorsal mesocardium connects the primitive 
atrial  chamber to the embryonic midline and to the pulmonary pit  (the entrance point of 
the pulmonary vein), and contributes to the primary atrial septum and to the pulmonary 
myocardium (Webb et al., 1998). Finally, cardiac neural crest cells are involved in 
development of aortic arches, and the septation and formation of the OT valves (Hutson 
and Kirby, 2007).  
Further in development, the heart undergoes asymmetric looping (E9), which converts 
the original A/P arrangement into the right-left polarity seen in the adult heart. The atrial 
and ventricular components are separated from one another by the atrioventricular canal 
(AVC), which becomes incorporated into both definitive atria as the vestibules of the 
atrioventricular  (AV)  valves  (Lincoln  et  al.,  2004).  Completion  of  the  left  atrium  
development requires formation of the lungs and pulmonary vasculature. As the lung buds 
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form,  a  plexus  of  vessels  develops  around  them  and  establishes  a  connection  with  the  
primary atrial component through the dorsal mesocardium, via the pulmonary vein. 
Concomitantly the atrial component of the primary heart tube has ballooned out, to either 
side of the OT, to form the right and left atria separated by primary septum (Moorman et 
al., 2003).  
Septation into the four definitive chambers in the mouse is completed by E14.5. 
Septum secundum provides continuity between the atria after the primary septum has 
closed completely, and the ventricles become separated by interventricular septum 
(Savolainen et al., 2009). However, the remodeling of the OT and AV cushions to form 
valves is an ongoing process that continues postnatally (Lincoln et al., 2004).  
The cardiac anatomy in the mouse and humans is remarkably similar, and only small 
variations can be seen in the development of venous components of the atria. Whereas the 
left atrium in human heart receives four pulmonary veins, in the mouse the pulmonary 
veins join together and empty via a single foramen into the dorsal wall of the left atrium. 
Moreover, in humans, the left superior caval vein (LSCV) regresses and the remaining 
proximal portion becomes the coronary sinus, whereas in mouse, the LSCV persists into 
postnatal life (Wessels and Sedmera, 2003). These differences account for the small size 
of the atrial components in the murine heart. 
 
1.3.1 Signals Specifying Heart Development 
 
1.3.1.1 Cardiac Crescent Induction  
Mesp1, the earliest indicator of cardiogenic mesoderm, drives commitment of 
mesodermal precursors to the cardiac lineage by downregulating mesodermal pluripotent 
genes and promoting the stable expression of cardiomyogenic transcription factors, 
including Nkx2.5, Isl1, Gata4, and Myocardin in the cardiac crescent, where myocardial 
cell differentiation fist takes place (Bondue et al., 2008). In addition, genes encoding for 
T-box and basic helix loop helix transcription factors, such as Tbx5 and Hand1/2 (basic 
helix–loop–helix),  as  well  as  Mef2c (MADS-box) factors, are also implicated in 
myocardial differentiation in the crescent, as well as later in the developing heart. 
Additionally, early expression of Isl1 is dependent on canonical Wnt and Fgf8 signaling, 
both  of  which  are  required  for  proliferation  of  early  cardiac  progenitors  (Cohen  et  al.,  
2007; Lin et al., 2007). These cardiac progenitors undergo rapid expansion to provide the 
necessary cells for the increase in size, concomitant with heart tube formation, looping, 
and chamber differentation.  
Whereas some factors specify cardiogenic mesoderm, others restrict the cardiogenic 
field. RA signaling imposes the posterior limit of the early cardiac crescent (Ryckebusch 
et al., 2008; Sirbu et al., 2008; Waxman et al., 2008). Wnt signaling also inhibits cardiac 
progenitor specification within the heart field, although it has also been shown to promote 
cardiac differentiation at earlier stages (Kwon et al., 2007). 
Three cell precursor populations have been identified in the splanchnic mesoderm: the 
first population, Nkx2-5+/Isl1+ which generates the cardiac crescent and subsequently the 
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FHF; the second population Nkx2-5+/Isl1- forming the SHF, which provides large 
contributions to the heart poles and dorsal mesocardium, and more laterally, the third 
population, Nkx2-5-/Isl1-, containing the sinus venosus progenitors (Mommersteeg et al., 
2010). Cardiogenic Nkx2-5+/Isl1+ cells  are  tri-potent  and  contribute  to  the  formation  of  
cardiomyocytes, endothelial cells, and vascular smooth muscle cells that are added to the 
developing functional heart (Moretti et al., 2006). 
 
1.3.1.2 Specification of the Venous Pole of the Heart 
The development of both venous entrances into the heart, the systemic sinus venosus 
and the pulmonary vein, takes place in close proximity to the venous pole of the heart. For 
long time, it was thought that the pulmonary myocardium and the myocardium of the 
sinus venosus have a common origin. However, in contrast to sinus venosus, the 
pulmonary myocardium develops from Nkx2-5+ Isl1- dorsal mesocardium, which  has  its  
origin in the medial cardiac crescent (Mommersteeg et al., 2007). Cell lineage analysis 
show that the pulmonary myocardium and atrial myocardium share the expression profile 
of  several  key  genes,  whereas  the  sinus  horn  myocardium  displays  a  distinct  profile  
(Garcia-Frigola et al., 2003; Soufan et al., 2004; Christoffels et al., 2006; Mommersteeg et 
al., 2010). 
 
1.3.1.3 Patterning of the heart along the axis 
During development, the heart is essentially polarized along its A/P and left–right axis. 
A key regulator of A/P patterning in the myocardial cells is RA signaling. In the linear 
heart tube, RA displays a posterior-to-anterior gradient, higher at the venous pole and 
decreasing towards the anterior part of the tube (Zile et al., 2000). At the arterial pole of 
the heart, RA signals are repressed by Tbx1 and Crkl1 (Crk-like protein 1). Reciprocally, 
RA signals reduces Tbx1 expression  in  SHF progenitors  that  will  contribute  to  posterior  
segments of the heart (Guris et al., 2006). 
Evidence of left–right patterning can be observed in asymmetrical expression of 
several genes during and after gastrulation. Nodal signaling activates the homeobox 
transcription factor Pitx2 in the left side of the lateral mesoderm and cardiac crescent and 
represses the acquisition of the right atrial identity and proliferation of cells surrounding 
the left sinus venosus (Franco et al., 2000; Ai et al., 2006). In vitamin A deficiency 
studies, heart looping was reversed, and the left-right determining genes Nodal and Pitx2 
were downregulated (Zile et al., 2000). 
SHH signaling is also involved in the left-right patterning of the heart, as Shh mutant 
embryos display left atrial isomerism with the heart attached to the dorsal mesocardium. 
Also, Cited2 gene controls cardiac left-right patterning, as Cited2- null allele mice display 
right isomerism and abnormal cardiac looping (Bamforth et al., 2004; Weninger et al., 
2005). 
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1.3.1.4 Chamber patterning 
During subsequent cardiac morphogenesis, the myocardium becomes subdivided into 
chamber myocardium (ventricles and atria), which undergo a “ballooning” phase of 
growth,  and  nonchamber  myocardium  which  becomes  represented  by  the  outflow  tract,  
AV canal, inner curvature and central conduction system myocardium. Delineation of the 
heart into chamber and nonchamber myocardium is achieved by a number of transcription 
factors that regulate activation or repression of region-specific gene expression. T-box 
transcription factors, including genes encoding for Tbx2, Tbx3, Tbx20, Tbx5, and Tbx18, 
confer regional identity of the heart (Christoffels et al., 2004). However, few regulators of 
chamber-specific gene expression have been identified, although each cardiac chamber 
has specific biochemical and physiological properties. The iroquois-related homeobox 
transcription factor gene, Irx4, together with the basic helix-loop-helix transcriptional 
repressor gene Hey2 confers ventricular identity by activating ventricular-specific gene 
expression and repressing atrial-specific gene expression (Bao et al., 1999; Wang et al., 
2001; Xin et al., 2007). Nkx5.2 regulates the restricted expression of Hand1/2 in the heart 
primordium. Eventually Hand1 gene becomes restricted to the left ventricle, while Hand2 
gene expression specifies only the right ventricle (McFadden et al., 2005). Tbx5 plays an 
important role in conferring atrial identity and establishing the boundary between left and 
right ventricles. Tbx5, a downstream target of RA signaling, is more abundant in the atria 
than in the left ventricle reflecting a RA gradient important for chamber specification 
(Bruneau et al., 1999). 
 
1.4  PLAKOPHILIN 2 (PKP2) 
 
1.4.1 Pkp2 Localization and Function 
 
Plakophilins are members of the armadillo family of proteins, characterized as 
scaffolding proteins that are required for desmosome assembly. Desmosomes are adhesive 
intracellular junctions characteristically present in epithelial cells (Cowin and Garrod, 
1983), linking together the intermediate filaments (IF) cytoskeletons of adjacent cells 
(Staehelin, 1974; Koeser et al., 2003).  
The Plakophilin subfamily comprises 4 members (Pkp1-4). In addition to their role in 
cell-cell adhesion, Pkp1 and Pkp2 have been also identified in the nucleus (Mertens et al., 
1996; Schmidt et al., 1997). Pkp2 was shown to be expressed in all proliferative epithelial 
tissues and tumors (Mertens et al., 1996; Mertens et al., 1999). 
Among Pkp subfamily members, Pkp2 is the only plakophilin expressed in the heart 
and Pkp2- null allele embryos die at mid-gestation, due to distorsions of heart 
morphogenesis, followed by cardiac rupture and blood leakage in the peritoneal cavity 
(Grossmann et al., 2004). Pkp2 binds through the N-terminal head domain to a large 
number of desmosomal proteins, including desmosomal cadherins (desmogleins and 
desmocollins), plaque proteins (desmoplakin, plakoglobin), but also to ?-catenin in 
adherens junctions (Hatzfeld, 2007; Bass-Zubek et al., 2009). 
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1.5 VISININ-LIKE 1 (VSNL1) 
 
1.5.1 VSNL1 Belongs to Neuronal Calcium Sensor (NCS) Family  
 
Visinin-like 1 (Vsnl1) gene localizes on chromosome region 2p24 and encodes for the 
191-amino-acid VSNL1 protein (also known as VILIP-1 or NVP-1), the founder member 
of  visinin-like  protein  (VSNLs)  subfamily  of  neuronal  calcium  sensor  (NCS)  family  of  
proteins (Braunewell and Gundelfinger, 1999). The NCS protein family includes a variety 
of intracellular calcium-sensing proteins, primarily expressed in nerve cells, and 
containing 4 EF-hand Ca2+ binding motifs, as well as a consensus motif for N-terminal 
myristoylation.  
Based on sequence alignment similarities, the 40 NCS proteins known to exist to date 
in several species have been classified into five subfamilies (Braunewell and 
Gundelfinger, 1999). The class III includes the VSNLs subfamily with 5 members 
(VSNL1, VSNL2, VSNL3, Hippocalcin and Neurocalcin-?), which share 67 to 94% 
homology in their amino acids sequences (Braunewell and Klein-Szanto, 2009). Vsnl1 
orthologs have been cloned from several species and named differently: VILIP-1 from 
chick (Lenz et al., 1992), fish and reptiles (Ren et al., 2010), neural visinin-like protein 1 
(NVP-1)  from  rat  (Kuno  et  al.,  1992),  neurocalcin  ? from  cow  (Kato  et  al.,  1998),  and  
VSNL1 from mouse and humans (Polymeropoulos et al., 1995). The amino acid 
sequences for VSNL1 orthologs are extremely well conserved between species (from 92.1 
up to 100%), suggesting a high selective pressure for VSNL1 function.  
 
1.5.2 Protein Structure, ‘Calcium - Myristoyl Switch’ 
 
VSNL1 protein displays the same structural topology of four EF-hand motifs (EF1-
EF4) as all members of the NCS protein family. The structure of the EF- hand domains 
consists of two ?-helical segments linked by a calcium-binding loop (Burgoyne and 
Weiss, 2001). The loop is formed by 12 amino acid stretches, six of which (designated as 
X, Y, Z, -Y, -X, -Z at positions 1, 3, 5, 7, 9, and 12) participate in the coordination of one 
calcium ion in every EF-hand domain (Braunewell and Klein-Szanto, 2009). 
The closest EF-hand motif to N-terminus, EF1, varies in its amino acid sequence 
among NCS proteins, and it is presumed to be the binding site for protein-protein 
interactions and it does not bind Ca2+. The other three hand motifs possess intact sequence 
motifs capable of binding calcium ions (Burgoyne and Weiss, 2001). VSNL1 also 
contains a N-terminal M-G-(X)3-S myristoylation consensus sequences and is 
myristoylated on a glycine residue at the second position on its polypeptide chain 
(Burgoyne and Weiss, 2001). Structural and biochemical studies of NCS proteins have led 
to the concept of the so called 'Ca2+-myristoyl switch', which enables the proteins to 
shuttle between different cellular compartments, and to reversibly interact with different 
interaction partners, such as signal effector proteins in distinct membrane compartments 
(Zozulya and Stryer, 1992; Ames et al., 1997). In a Ca2+- free state, the myristoyl group is 
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sequestered in a hydrophobic pocket. Upon Ca2+ binding, the protein undergoes a 
conformational change where EF1 and EF2 are relocated, the myristoyl residue is 
extruded, and the protein adopts a more extended conformation, enabling interaction with 
cellular membranes (Zozulya and Stryer, 1992; Ames et al., 1997). 
In the absence of Ca2+, or when the EF- hand motifs are mutated, significant amounts 
of VSNL1 remain membrane-associated (Spilker et al., 2002), and its ability to associate 
with the membranes is abolished only when the myristoylated residue is mutated (Gly2 to 
Ala2), suggesting that the myristoyl moiety is constitutive exposed, due to structural 
changes caused by mutations in the EF-hand motifs (Spilker et al., 1997; Lin et al., 
2002a). 
 
1.5.3 VSNL1 Expression Pattern  
 
1.5.3.1 Nervous System  
VSNL1 is abundantly expressed in the brain, exclusively in neuronal cells. However, 
its expression is differentially distributed in CNS (central nervous system) between 
species. In adult rat, Vsnl1 mRNA has a widespread expression pattern in most brain areas 
except the caudate-putamen (Paterlini et al., 2000). In rat hippocampus, VSNL1 is highly 
expressed in all regions and dentate gyrus (Zhao and Braunewell, 2008), in contrast to 
gerbils, where VSNL1 immunoreactivity is strongest in the hippocampal region, CA3 
(Lenz et al., 1996b), and humans, where strong expression is detected in hippocampal 
areas CA1, CA4 and in the hilus of the dentate gyrus (Bernstein et al., 1999). In chicken, 
Vsnl1 transcripts are primarily found in the granule cell layer of the cerebellum (Lenz et 
al., 1992) and in addition, the protein is also detected in the molecular layer of the rat 
cerebellum (Spilker et al., 2000). In the eye, VSNL1 is expressed in a subset of neurons in 
the inner retina (bipolar, amacrine and retinal ganglion cells) of various species (De Raad 
et al., 1995) and most prominently in the optic tectum of chicks (Lenz et al., 1992). In the 
reptile, Gekko japonicus, Vsnl1 transcripts are strongly expressed in the gray matter and 
ependymal cells of the spinal cord (Ren et al., 2010). 
In  peripheral  nervous  system  (PNS),  VSNL1  is  expressed  in  a  subset  of  primary  
sensory neurons of the rat nasal epithelium, predominantly concentrated in cilia and 
dendritic knobs of the olfactory bulbs, the chemosensory compartments of olfactory 
neurons (Boekhoff et al., 1997).  
 
1.5.3.2 VSNL1 Expression in Peripheral Organs 
Ouside of the nervous system, VSNL1 distribution shows a developmental decrease of 
expression in liver, lung, kidney, spleen, pancreas and colon, when late embryonic stages 
are compared with adult rat tissues, possibly indicating a specific function during organ 
development (Gierke et al., 2004).  
By using different approaches as bioinformatics, Western Blot and RT-PCR analysis, 
VSNL1 has been detected in rat and human heart, testis, ovary, stomach and skin 
(Kajimoto et al., 1993; Ohya and Horowitz, 2002; Gierke et al., 2004; Buttgereit et al., 
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2010). Furthermore, Vsnl1 has been identified by RT-PCR in adult murine gastrointestinal 
smooth muscle cells (Ohya and Horowitz, 2002), and its expression at the protein and 
mRNA levels has been detected in adult human esophagus and basal keratinocytes of skin, 
as well as in murine pancreatic islets, specifically in insulin expressing ?-cells and 
glucagon-expressing ?-cells (Mahloogi et al., 2003; Dai et al., 2006; Wickborn et al., 
2006). In adults gerbils, VSNL1 is ubiquitously expressed in all tissues including lung, 
liver, heart, ovary and kidney (Ren et al., 2010). 
 
1.5.4 VSNL1 Mode of Action 
 
1.5.4.1 One Protein, Multiple Functions 
Most of the functions for VSNL1 are derived from in vitro studies. VSNL1 was first 
isolated in a screen for proteins expressed during terminal differentiation of the optic 
tectum in chicken, pointing to a role of VSNL1 in cell differentiation (Lenz et al., 1992). 
Further studies show that VSNL1 indeed induces differentiation and maintenance of the 
mature cellular phenotype of C6 glioma cells (Boekhoff et al., 1997). 
VSNL1 modulates both the cyclic adenosine monophosphate (cAMP) and cyclic 
guanosine monophosphate (cGMP) signaling in a calcium dependent manner in various 
cell contexts (Braunewell and Klein-Szanto, 2009). In addition to adenylyl cyclases, 
VSNL1 also influences the retinal and non-retinal receptor guanylyl cyclases (GC-A and 
GC-B), the natriuretic peptide B receptor and P2X2 receptor, by increasing their surface 
expression (Braunewell and Klein-Szanto, 2009). In murine pancreatic ? cells, Vsnl1 
modulates insulin secretion and is upstream of genes involved in cell-cycle regulation, 
such as Cyclin D2, Gsk3?,  and  cAMP response  element  binding  (CREB) and pancreatic 
and duodenal homeobox 1 (Pdx-1) transcription factors (Dai et al. 2006). VSNL1 was 
discovered to be a double stranded RNA binding protein that can recognize structured 
regions of mRNAs. In a Ca2+ dependent manner, VSNL1 binds to 3’ UTR of neurotrophic 
tyrosine kinase receptor, TrkB in the dendrites of hippocampal neurons (Mathisen et al., 
1999) and to actin cytoskeleton in chicken brain (Lenz et al., 1996a). Additionally, both, 
in vitro and in vivo studies indicate a role of VSNL1 in protein-expression dependent 
forms of synaptic plasticity by activating the group I metabotropic glutamate receptor 
(mGlu) (Braunewell et al., 2003; Brackmann et al., 2004). 
Several interacting partners have been identified for VSNL1. It forms dimers with 
itself and with the closely related protein VSNL3 in a Ca2+- independent manner (Jheng et 
al., 2006). VSNL1 interacts with ???2 nicotinic acetylcholine receptors (nAChR) in a 
complex with the trans-Golgi SNARE syntaxin 6, which is involved in post-Golgi 
membrane trafficking and exocytotic processes, and modulates ???2 nAChR function and 
trafficking (Lin et al., 2002b; Zhao et al., 2009). VSNL1 interferes also with the recycling 
of transfferin receptor and clathrin distribution (Brackmann et al., 2005), suggesting a 
general role as modulator of membrane trafficking. 
It also forms a signaling complex with ATP P2X2 receptors and proteins such as N-
ethylmaleimide-sensitive factor (NSF), tubulin1?, vesicle amine transport protein 1 
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homolog  (VAT1),  glutamic  acid  decarboxylase  (GAD),  and  synapsin  IIB  (Chaumont  et  
al., 2008).  
 
1.5.4.2 VSNL1 is a Marker of Neurological Disorders 
The chromosome region 2p24, where the human VSNL1 gene lies, is considered to be a 
hot spot for the susceptibility genes linked to schizophrenia (Bulayeva et al., 2007; Hong 
et al., 2009). A shift in the VSNL1 cellular expression from the pyramidal neurons to 
interneurons has been observed in hippocampi of schizophrenics, and this shift is more 
intense in the left hemisphere hippocampus (Bernstein et al., 2002; Gierke et al., 2008). 
The reduced expression of VSNL1 in the hippocampal neurons has been further confirmed 
by genome wide analysis, proteomic studies and animal models (Bernstein et al., 2003; 
Miklos and Maleszka, 2004; Vercauteren et al., 2007). Moreover, a significant association 
of single-nucleotide polymorphisms (SNPs) in VSNL1 gene with schizophrenia and frontal 
cortical function has been identified in patients with diagnoses of schizophrenia 
(Braunewell et al., 2011). 
VSNL1 has also been linked to stroke, since high level of VSNL1 is detected in the 
cerebrospinal fluid (CSF) and blood of patients after stroke and in a stroke animal model 
(Laterza et al., 2006). 
A significant decrease in the number and staining intensity of VSNL1 expressing 
neurons is observed in the temporal cortex of patients with Alzheimer disease (AD). 
Further evidence for VSNL1 association to AD comes from genome wide expression 
analysis, where VSNL1 was found among the genes correlated with the progression of AD 
(Braunewell et al., 2001; Loring et al., 2001; Gomez Ravetti et al., 2010). Further, in the 
brain from patients with AD, VSNL1 associates with extracellular plaques and fibrillar 
tangles, and in in vitro studies in neuronal cells, VSNL1 induces the hyperphosphorylation 
of TAU protein and enhances calcium mediated neurotoxicity (Schnurra et al., 2001). 
 
1.5.4.3 VSNL1 in Carcinogenesis 
Vsnl1 is involved in the pathophysiology of cancer and plays dual role as a tumor 
suppressor gene or as an oncogene, depending on cellular context. The precise signaling 
mechanisms leading to the opposite effects in different cell types are currently under 
investigation. 
Both in vitro and in vivo studies on murine skin cancer models show that VSNL1 
expression decreases with invasiveness and its ectopic expression reduces proliferation, 
migration and invasiveness, but also susceptibility to skin cancer, suggesting a tumor 
suppressor activity (Mahloogi et al., 2003; Gonzalez Guerrico et al., 2005; Fu et al., 2010). 
Overexpression of VSNL1 in highly invasive squamous carcinoma cells (SCC) leads to 
an increase in cAMP resulting in reduced levels of metalloproteinase 9 (MMP-9) and ?5 
integrin, and a decrease in RhoA activity (Gonzalez Guerrico et al., 2005). Loss of VSNL1 
expression has been observed in invasive human esophagus and lung cancers and it was 
correlated with the depth of tumor invasion and local lymph node metastasis, but not with 
the tumor cells proliferation rate (Wickborn et al., 2006; Fu et al., 2008). In non-small cell 
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lung carcinoma (NSCLC) cell lines and human tumor samples, VSNL1 expression is 
regulated by DNA methylation, and no gene mutations, deletions or rearrangements are 
found to occur, suggesting its clinical potential as a predictor of short-term survival in 
lung cancer patients (Fu et al., 2008).  
In contrast, VSNL1 is overexpressed in neuroblastoma, and it enhances neuroblastoma 
invasiveness, suggesting an oncogene function. Moreover, in tumor specimens, VSNL1 
levels correlate significantly with the metastatic outcome, and account for invasive 
phenotypes (Xie et al., 2007). 
Finally, increased expression of VSNL1 leads to upregulation of anoikis inhibitor TrkB 
and the downregulation of intracellular adhesion molecule 1 (ICAM-1), major 
histocompatibility  complex  class  I  (MHC-1),  and  cell  adhesion  molecules  CD44  and  
CD44v6, therefore enhancing tumor cell invasion properties (Xie et al., 2007). Also, in 
colorectal cancer (CRC), both the mRNA and VSNL1  protein expression are associated 
with a high rate of lymph node metastasis and poor patient prognosis, suggesting an 
oncogenic  role  and  the  possibility  of  its  use  as  a  novel  biomarker  in  CRC (Akagi  et  al.,  
2011). 
 
1.6 PLEXIN AND SEMAPHORIN FAMILIES 
 
1.6.1 Plexins 
 
Plexins  (Plxn)  constitute  the  receptors  for  Semaphorins  (Sema)  and  were  first  
identified in the nervous system, where semaphorins act as axon guidance cues. Their 
implication in cardiovascular system, immune system and in tumor progression have been 
only recently revealed (Neufeld and Kessler, 2008; Zhou et al., 2008b). Based on 
structural studies, the mammalian glycoprotein family of Plexins comprises 9 different 
components divided into four subgroups: Plexin A1-A4, B1-B3, C1 and D1 (Artigiani et 
al., 1999; Tamagnone et al., 1999). 
Plexin proteins consist of an extracellular and a cytoplasmic conserved domain. The 
extracellular domain share similarities with both Met tyrosine kinase family and 
semaphorins, and contain a Sema domain and two to three Met-related sequence (MRS)- 
domains (Kolodkin et al., 1993; Maestrini et al., 1996; Winberg et al., 1998), several 
potential N-glycosylation sites (Kameyama et al., 1996b; a; Maestrini et al., 1996), and 
several glycine-proline-rich immunoglobulin (Ig)-domains (IPT) (Bork et al., 1999). The 
Sema domain participates in the protein-protein interactions, such as receptor dimerization 
and binding to ligands (Gherardi et al., 2004). The same function has been suggested also 
for the MRS domains. 
The cytoplasmic domain of Plexins contain 13 conserved tyrosine residues that can be 
phosphorylated, but no intrinsic tyrosine kinase activity has been described (Franco and 
Tamagnone, 2008). It also contains two R-Ras guanosine triphosphatase (GTPase)-
activating proteins (GAP)-like motifs and in between, a Rho GTPase binding domain 
(RBD), which includes Plexin Rho GTPase associated motifs (PRAMs) (Driessens et al., 
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2001; Hu et al., 2001; Whitford and Ghosh, 2001). The PlexinB- subfamily have in their 
extracellular domain a cleavage site for proprotein convertases (Tamagnone et al., 1999), 
and therefore they exist predominantly as heterodimers on the cell surface. The proteolytic 
cleavage of PlexinB1 increases its binding affinity to its ligand, Sema4D, and it is 
necessary for the functional response (Artigiani et al., 2003). Additionally, the 
cytoplasmic C-terminus contains a PDZ interaction motif (Swiercz et al., 2002). 
 
1.6.2 Semaphorins 
 
Semaphorins are divided into 8 classes based on their origin and structure (Semaphorin 
Nomenclature Committee, 1999). Classes 1, 2 and 5 consist of invertebrate semaphorins, 
whereas classes 3-7 comprise 20 vertebrate semaphorins. Most of semaphorins consist in 
one sema domain, a MRS repeat embedded in the Sema domain and an Ig repeat 
(Kolodkin et al., 1993; Ohta et al., 1995). Semaphorins from class 4, for example 
Sema4D, can be cleaved by metalloproteinases (Elhabazi et al., 2001), and this cleavage is 
important for their function (Basile et al., 2007). In addition, they contain the same PDZ 
interacting domain at the end of the cytoplasmic domain similarly to PlexinB protein 
subfamily. 
 
1.6.3 Semaphorin-PlexinB Signaling 
 
Most of the semaphorins bind to and use plexins as receptors. In addition to plexins, 
semaphorin receptor complexes often contain other proteins, such as neuropilins (Nrp), 
integrins or receptor tyrosine kinases (RTKs) (Zhou et al., 2008b). The downstream 
targets of different semaphorin-plexin combinations vary, but a common target is the 
cytoskeleton. Semaphorins of classes 4 and 5 interact with PlexinsB- subfamily. Sema4D 
binds, with different affinity to both PlexinB1 and PlexinB2 (Tamagnone et al., 1999; 
Masuda et al., 2004), but greater preferences are seen for PlexinB1 (Deng et al., 2007). 
Sema4C is the preferential ligand of PlexinB2 (Deng et al., 2007). Recently, Sema4A was 
shown to bind to and signal through all three plexins of the B- subfamily (Yukawa et al., 
2010), while Sema5A binds specifically to Plexin B3 (Artigiani et al., 2004). 
The PlexinB- subfamily have been shown to interact with the HGF receptor, Met, 
independently of semaphorins (Giordano et al., 2002), but also with other RTKs, ErbB-2 
and Ron (Artigiani et al., 2004; Swiercz et al., 2004; Deng et al., 2007). ErbB-2 is 
necessary for the activation of RhoA by Sema4D-PlexinB1 signaling via Rho-GEF 
(Swiercz et al., 2004), whereas Met is required for the inhibitory effect on RhoA activity 
(Swiercz et al., 2008). 
The binding of the ligand to plexins, but not to the RTKs, results in the activation of 
both receptors and an increase in downstream signaling. The phosphorylation of PlexinB1 
or B2 by ErbB-2 creates a docking site for SH2 domain-containing proteins such as 
phospholipase C (PLC?). The interaction is necessary for Sema4D- induced RhoA 
activation (Swiercz et al., 2009). Stimulation of PlexinB1 and ErbB-2 with Sema4D, also 
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causes the activation of the downstream pathway of ErbB-2 as well, including Shc and Erk 
(Swiercz et al., 2004). Therefore, the outcome of Sema4D-PlexinB1 signaling on cellular 
behavior depends greatly on the cellular context.  
 
1.6.4 PlexinsB-Subfamily in Mammalian Development and Disease 
 
1.6.4.1 Nervous System 
In the nervous system, Plxnb1 displays the widest pattern of expression in the 
embryonic brain where it mostly overlaps with the expression of Plxnb2. They are both 
found in the developing forebrain, midbrain, cerebellum and the neuroepithelium that lines 
the ventricles of the brain, and in the spinal cord. In contrast, Plxnb3 shows no expression 
during mouse embryogenesis and it becomes apparent only after birth in the brain white 
matter (Worzfeld et al., 2004). 
Sema4D, the ligand of PlexinB1 and PlexinB2, is expressed throughout the murine 
CNS before birth (Furuyama et al., 1996; Worzfeld et al., 2004), in a complementary 
pattern to that of Plxnb1. After  birth,  the  expression  pattern  of  Sema4D switches from 
neuronal to the myelinating oligodendrocytes in white matter (Moreau-Fauvarque et al., 
2003; Worzfeld et al., 2004). Although the CNS develops normally in the absence of 
Sema4d (Shi et al., 2000), the mice deficient for the ligand display an increased number of 
mature oligodendrocytes in the cerebellar cortex (Taniguchi et al., 2009). 
Contrary to the normal phenotype seen in Plxnb1- null allele mice, the absence of 
Plxnb2 causes severe development neuronal defects (Deng et al., 2007; Friedel et al., 
2007). Depending on the mouse background, the phenotype varies from embryonic 
lethality, due to defects in the closure of the neural tube (exencephaly) and an inverse 
topography of the brain, in the inbred C57BL/6 background (Plxnb2-/-C57Bl), to an altered 
cerebellar structure and 30% survival in CD1 genetic background (Plxnb2-/-CD1) (Deng et 
al., 2007; Friedel et al., 2007). In addition, Plxnb2-/- mice display an altered development 
of the dentate gyrus and olfactory bulb (Deng et al., 2007). 
Sema4c overlaps the expression of Plxnb2 in the olfactory bulb and dentate gyrus 
during development and in the adult cebellar granule cells, and it has been suggested that 
Sema4C is the ligand that signals through PlexinB2 in these specific locations (Deng et 
al., 2007). Outside of cerebellum, Sema4d is expressed in the cortical plate, 
complementary to Plxnb1 and Plxnb2 expression pattern, suggesting that Sema4D rather 
then Sema4C is the functional ligand of PlexinB2 (Hirschberg et al., 2009). 
Plxnb3- null allele mice display no abnormal phenotypes (Worzfeld et al., 2009), but 
in humans, Plxnb3 haplotype is genetically associated with increased volume of white 
matter in the brain and better cognitive abilities (Rujescu et al., 2007). After murine 
midgestation, Plxnb1 and Plxnb2 (at  lower  extent)  are  also  detected  in  the  dorsal  root  
ganglia (DRGs) in the peripheral nervous system (PNS) (Masuda et al., 2004; Worzfeld et 
al., 2004). 
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Sema4d is expressed in the developing DRGs and it promotes the axonal outgrowth of 
embryonic DRG neurons dependent on Nerve growth factor (NGF) signaling (Masuda et 
al., 2004). 
 
1.6.4.2 Immune System 
In the immune system, Sema4d is expressed in normal CD5- positive B cells. In mice 
depleted of Sema4d, B cell aggregation and proliferation, as well as the priming of T cells, 
are defective (Shi et al., 2000). PlexinB1 protein, on the other hand, is expressed by the 
bone marrow stromal cells, activated T lymphocyte and follicular dendritic cells 
(Granziero et al., 2003), crucial sites for interaction with B cells, but no defects in B cell 
development have been reported in the Plxnb1-/- embryos. Sema4D signaling in 
lymphocytes which do not express PlexinB1 is mainly driven through another receptor, 
CD72 (Kumanogoh et al., 2000). 
In immature dendritic cells (DCs), PlexinB1 is necessary for triggering the negative 
effect  of Sema4D on migration and the stimulating effect  on cytokine production. These 
effects are dependent on the presence and availability of PlexinC1 (Chabbert-de Ponnat et 
al., 2005). Sema4D produced by active T lymphocytes plays also a role in 
neuroinflammation and associated demyelination through PlexinB1. Normally, Sema4D is 
expressed in the kidney tubules, whereas PlexinB1 expression is seen in the tubules and 
glomeruli. Sema4D- expressing macrophages are recruited to the glomeruli, suggesting 
that interactions between PlexinB1 and Sema4D in the glomeruli and leucocytes would 
facilitate glomerular leucocyte recruitment (Li et al., 2009). 
Accordingly, in the experimental crescentic glomerulonephritis model, the absence of 
Sema4d reduces the amount of glomerular injury, and the lack of Sema4d resulted in 
suppression of both cellular and humoral systemic immune responses (Li et al., 2009). 
 
1.6.4.3 Angiogenesis 
Both in vivo and in vitro studies have suggested a role for Sema4D in angiogenesis 
(Basile et al., 2004; Conrotto et al., 2005).  In Sema4d- null allele mice, the maturation of 
tumor vessels is impaired (Sierra et al., 2008), suggesting a role for Sema4D in tumor 
growth and metastasis by promoting angiogenesis (Basile et al., 2007; Sun et al., 2009). In 
contrast, Plxnb1-/- mice  do  not  show  defects  in  the  development  of  blood  vessels  or  
angiogenetic response induced by tumor growth (Fazzari et al., 2007). In zebrafish, 
PlexinB2 regulates the sprouting of the vessels that connect the dorsal aorta (DA) and the 
right dorsal longitudinal anastomotic vessels, as knockdown of either Sema3e or Plexinb2 
causes delayed sprouting of these vessels (Lamont et al., 2009). In the mouse retina, 
Sema3E–PlexinD1 functions in modulating angiogenesis via a VEGF- induced feedback 
mechanism (Kim et al., 2011). 
 
1.6.4.4 Cancer 
Depending on the cellular context, the PlexinB subfamily members can function as 
inducers or suppressors of tumor growth (Neufeld and Kessler, 2008). Sema4D-PlexinB1 
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activating Met induces tumor invasiveness in liver progenitor cells (MLP29) (Giordano et 
al., 2002), and in breast and ovarian cancers (Valente et al., 2009). Plxnb1 missense 
mutations are identified in prostate cancer samples from patients and in cancer cell lines 
(Wong et al., 2007). In brain tumors, the expression of Plxnb2 correlates with malignancy 
(Shinoura et al., 1995), while the expression of both PlexinB3 and Sema5A correlate with 
tumor progression in gastric cancer (Pan et al., 2009). On the other hand, in clear cell renal 
carcinoma, melanoma and in estrogen receptor (ER)-positive breast cancer, PlexinB1 
functions as a tumor suppressor (Rody et al., 2007; Gomez Roman et al., 2008; Argast et 
al., 2009; Rody et al., 2009). 
 
1.6.4.5 Developing Kidney  
In the mouse, Plxnb1 is expressed by the ureteric epithelium, glomeruli and 
undifferentiated mesenchyme after midgestation (Fazzari et al., 2007; Kobayashi et al., 
2008). In the adult kidneys its expression is restricted to distal tubules and collecting ducts 
(Fazzari et al., 2007; Kobayashi et al., 2008). 
Branching morphogenesis is increased in Plxnb1-/- embryos, the kidney area is bigger 
then the wild type littermates, but the adult kidneys are normal and functional (Fazzari et 
al., 2007).  
Sema4D decreases ureteric branching in vitro, whereas the antibody blocking Sema4D 
activity has an opposite effect (Korostylev et al., 2008). This suggests that in the kidney, 
Sema4D signals through PlexinB1 and the effect is mediated through ROCK and the 
activation of RhoA, independently of Met (Korostylev et al., 2008). However the 
phenotype of Plxnb1-/- is somehow compensated until birth, by a possible redundancy with 
PlexinB2. The function of other B-subfamily Plexin, PlexinB2 has not been studied earlier 
in the developing kidney, even though its expression pattern is similar to PlexinB1. 
Plexins have been shown to interact and activate Met receptor tyrosine kinase (Giordano 
et al., 2002). On the other hand, GDNF signaling through Met, was shown to promote 
tubulogenesis, in the absence of Ret (Popsueva et al., 2003). 
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2 AIMS OF THE STUDY 
 
 
 
The aims of my study were: 
 
? to identify novel genes that are early responsive to GDNF in ureteric bud 
epithelium development.  
      
? to understand the role of VSNL1 and Pkp2 in ureteric branching morphogenesis 
and in the signaling hierarchy triggered by GDNF. 
 
? to examine the expression pattern of VSNL1 during mouse embryogenesis outside 
the nervous system, in order to get new insights into the possible function of 
VSNL1 in development. 
 
? to study the function of PlexinB2 in kidney development by analyzing the Plxnb2- 
null allele mice 
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3 MATERIALS AND METHODS 
 
The methods used in this study are described in details in “Materials and Methods” 
section in each original publication. The experimental procedures that required the use of 
laboratory animals were performed according to ethical guidelines of the European 
convention and approved by local authorities. Table 1 summarises the experimental 
methods, Table 2 details the in situ hybridization probes and Table 3 describes the 
antibodies used in this thesis.  
The mouse strains and the main techniques are described in more detail below. 
 
Table 1. Methods used and described in articles I-III 
Method Used in 
RNA extraction and RT-PCR  I, III 
Whole mount  and sectional  ISH  I, II, III 
Vibratome sectioning  I, II, III 
Mice breeding and PCR genotyping  1, II, III 
Immunohistochemistry and immunofluorescence  I, II, III 
Microdissection and tissue culture  I, II, III 
Production of Sema4C ligand PlexinB2antibody  III 
Affimetrix array analysis I 
Immunoprecipitation  III 
Protein extraction and Western blotting  I, III 
Histological analysis  III 
Statistical analysis  I, III 
TUNEL-apoptosis assay  III 
BrdU-proliferation assay III 
Paraffin sectioning  I, II, III 
Planning and cloning of ISH mRNA probes I 
Luciferase assay and cell trasnfection I 
X-gal staining I 
Fluo4 staining I 
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Table 2. The probes used for the in situ hybritization in articles I-III 
Probe Reference or origin Used in 
Arg2  IMAGE-clone 5254031 I 
Crlf1  Alexander et al., 1999  III 
Cxcr4  Zou et al., 1998 III 
Etv4 Lin et al., 1998 III 
Etv5 Trokovic et al., 2005 III 
Frem2 Jadeja et al., 2005 I 
Gdnf  a gift from JG Pichel III 
Gfra1  Suvanto et al., 1997 III 
Myb  Lu et al., 2009 III 
Pax2  Dressler et al., 1990 III 
Pkp2 IMAGE-clone 2647509 unpublished (I) 
Plxnb2  IMAGE-clone 5151635  III 
Raldh2  Niederreither et al., 1997 III 
Ret  Pachnis et al., 1993 I, III 
Sema4c IMAGE-clone:6836945 III 
Sprouty-1  Zhang et al., 2001 III 
Vsnl1  IMAGE-clone 5687661 I 
Wnt9b  Carroll et al., 2005 III 
Wnt11  Kispert et al., 1996 I, III 
 
Tabel 3. Antibodies used in articles I-III 
Probe Company, reference or origin Used in 
Vsnl1 gift from KH Braunewell I, II, III 
Calb1 Sigma I 
dp-ERK Sigma I 
p-HIST3 Upstate I 
?-tubulin Sigma I 
PCNA BD Biociences I 
?-catenin BD Transduction Lab. I 
PlexinB2 Whashington Biotech. III 
PlexinB2 Biotin eBioscience III 
Pan-cytokeratin  Sigma I, III 
Ret Santa Cruz III 
Sox9 Stolt et al. 2003 III 
Vinculin BD III 
p-Met Biosource, Invitrogen III 
p-ErbB2 Abcam III 
Endomucin Hycult Biotech II 
CT3 DSHB at Univ. of Iowa II 
Sm22? Abcam II 
NCAM Chemicon Int. I 
Actin Santa Cruz I, III 
Brush-Border gift from Aaro Miettinen III 
BrdU Amersham, GE Healthcare III 
Fluoro-conjugates Company, reference or origin Used in 
PNA Vector Laboratories III 
DAPI Vector Laboratories I, II, III 
Phalloidin Invitrogen I, III 
Alexa 488 Invitrogen I, II, III 
Alexa 563 Invitrogen I, II, III 
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3.1 Mice and Genotyping (I, II, III) 
 
Mouse  (Mus musculus) embryos/pups used for these studies were collected starting 
from E7 and up to four month of age. The morning of the vaginal plug was counted as 
E0.5  for  all  strains.  The  age  of  the  animals  was  confirmed  by  morphological  criteria.  
Gdnf- (Pichel et al., 1996), Ret- (Schuchardt et al., 1994), Plxnb1- (Fazzari et al., 2007) 
and Plxnb2- null allele mice (Friedel et al., 2007) in the C57BL/6 background as well as 
the wild-type animals from C57Bl and NMRI strains were maintained at the Research 
Animal Center of the University of Helsinki. Wnt11-/- embryos (Majumdar et al., 2003), as 
well as ?-catenin gain-of-function (?-catGOF-UB) (Bridgewater et al., 2011) and ?-catenin 
deficient (?-catu????) (Bridgewater et al., 2008), together with BAT-gal embryos (Maretto 
et al., 2003), were gifts from S. Vainio, N.D. Rosenblum and I. Thesleff, respectively. The 
embryos from the uterus or adult tissues were dissected under a light microscope, and 
cultured and/or fixed in 4% paraformaldehyde (PFA) as previously described (Sainio, 
2003). 
 
3.2 Tissue Culture (I, III) 
 
Kidney rudiments including the gonadal ridge, mesonephros, WD, and the MM were 
dissected at E10 to E12 and cultured on Nuclepore (Costar) filters in culture media 
(DMEM supplemented with 10% fetal bovine serum (FBS), 2 mM l-glutamine, 100 
units/ml streptomycin, and 100 units/ml penicillin) as described (Sainio, 2003). To induce 
supernumerary budding along the WD, half of the urogenital block was cultured with 15 
or 50 ng/ml exogenous GDNF (R&D Systems), while the other half served as a control.  
For the microarray study, the urogenital blocks were cultured for 16 hours with or 
without GDNF. This time point was chosen because it is just prior to any morphological 
changes in ureteric budding from the WD become evident. A segment of WD with as little 
as possible of the surrounding mesenchyme was microdissected between mesonephric and 
metanephric  regions  and  was  subjected  to  RNA  extraction.  The  UBs  and  MM  were  
isolated after treating the E11 or E12 kidneys with pancreatin-trypsin solution and 
thereafter separating the tissues microsurgically by needles (Sainio, 2003). The isolated 
UBs were transferred to adhere to different ECM coatings (laminin, Sigma; fibronectin, 
Sigma; collagen, Millipore; or Matrigel, BD Biosciences) or they were grown for 5-6 days 
in  a  three  dimensional  culture  in  Matrigel.  The  matrigel  was  prepared  by  dilution  of  the  
matrix 1:2 with the UB culture medium containing DMEM/F12 supplemented with 10% 
charcoal/dextran-treated FBS (Hyclone), 200 nM all-trans-retinoic acid and 9-cis retinoic 
acid (Sigma) and with different combinations of 30-50 ng/ml recombinant rat GDNF, or 
with 100 ng/ml FGF7 and 100 ng/ml Follistatin (R&D Systems). After 2-24 hours of 
incubation, the matrix was covered with UB culture medium containing no matrigel. The 
isolated MMs from E11.5 kidneys were cultured on Nuclepore filters as previously 
described in standard conditions with or without 5 ?M of 5’-bromoindirubin-3’-oxime 
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(BIO; Calbiochem) for 48 hours and 3 days thereafter in standard medium without BIO 
(Kuure et al., 2007). 
 
3.3 Affymetrix Array Analysis (I) 
 
The microdissected tissues (described above) were snap frozen in Trizol (Invitrogen) 
and taken to RNA extraction. Total  RNA was extracted from four sample pairs and then 
purified with an RNA-easy Cleanup Kit (Qiagen). The RNA quality was confirmed with 
2100 Bioanalyzer (Agilent Technologies). 50 ng RNA were used for cDNA synthesis and 
amplification (Roche's Microarray Target Amplification Kit), followed by in vitro 
transcription to biotin labeled amplified RNA (aRNA) (Roche's Microarray RNA Target 
Synthesis Kit). The labeled aRNA was then fragmented and hybridized to Affymetrix 
GeneChip® mouse genome 430 2.0 microarrays. The microarrays were scanned with 
Affymetrix GeneChip scanner, using streptavidin-conjugated fluorochromes to visualize 
the bound aRNA. The data was then analyzed using R/Bioconductor packages such as 
affy, limma, and ade4 (Gentleman et al., 2004; Reimers and Carey, 2006). Raw intensity 
measures were normalized using RMA with a custom Chip Definition File, with probes 
reannotated for 16331 Entrez genes (version 12) obtained from RAINARRAY. Expression 
differences were quantified using linear fitting for the paired design, with sample pairs and 
GDNF treatment as factors, using the limma package (Irizarry et al., 2003; Smyth, 2004; 
Dai et al., 2005). By using a P-value cutoff of 0.05, 1102 differentially expressed genes 
were identified. As the number of expected false positives at this threshold was too high, 
we used an additional cutoff, the fold change of 1.890, corresponding to GDNF co-
receptor- Gfr?1. 
 
3.4 In Situ Hybridization (I-III) 
 
Non-radioactive section in situ hybritization (ISH) was performed with Ventana 
Discovery ISH automate (Roche Diagnostics) on 5-7 ?m paraffin sections. Whole-mount 
ISH was carried out with InSituPro automate (Intavis, Cologne, Germany) as previously 
described (Kuure et al., 2005). For more detailed analysis, the samples were cut to sections 
(8-15 ?m) with Leica VT1000S vibratome (Leica Microsystems, Germany), after 
embedding into 4-5% low melting temperature agarose (BioWhittaker Molecular 
Applications,  USA),  in  PBS.  The  sections  were  mounted  in  50%  glycerol  and  
photographed with a Leica stereo-microscope equipped with a DC300 camera and IM1000 
software. 
The  ISH  probes  were  digoxigenin  (DIG)-labeled  antisense  cRNA  probes.  The  sense  
probes were used as controls. Vsnl1 full-length cDNA was subcloned into pYX-Asc 
vector. The plasmid was then linearized with SalI and  transcribed  with  T3  RNA  
polymerase for the antisense probe and for the sense probe with T7 RNA polymerase, 
after MfeI linearization. The details of the other probes are summarized in Table 2. 
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3.5 Immunohistochemistry, Immunofluorescence and X-gal Staining (I-III) 
 
Whole embryos, embryonic tissues (kidney and heart) or adult hearts were fixed with 
4% PFA for 1-3 days at 4°C, and then dehydrated through ethanol series, embedded in 
paraffin and sectioned at 5 ?m. The morphology of the samples was assessed by 
haematoxylin-eosin staining. The antibodies used in the studies are listed in Table 3 and 
described in detail in the original articles. Immunohistochemistry (IHC) on sections was 
carried out with Powervision+ Poly HRP histostaining kit (Leica Microsystems). For the 
anti-PlexinB2 antibody, tyramine signal amplification (TSA) together with Histomouse-kit 
(Zymed) were used (Adams, 1992). The sections were counterstained with haematoxylin 
and mounted with 20% Mowiol 4-88 (Calbiochem). Whole mount immunofluorescence 
on embryonic mouse tissues was performed on samples fixed with methanol or 2.5% PFA, 
washed extensively with PBS and stained as previously described (Sariola et al., 1988). 
The incubation of both, the primary and secondary antibodies was carried out overnight at 
4°C  in  PBS  containing  0.8%  Triton-X,  5%  normal  goat  serum  and  1%  DMSO.  The  
washes were done in the same medium. Samples were mounted with Vectashield DAPI 
(Vector Laboratories) to visualize the nuclei. The samples were analyzed with a Zeiss 
Axioplan II microscope with epifluorescence and photographed. X-gal staining for  
?-galactosidase was performed as described previously (Godin et al., 1998). For X-Gal 
staining, E11.5 urogenital blocks were microdissected in sterile Dulbecco's PBS as 
described above, fixed in PFA, stained for X-Gal, cut into 8 µm slices, and costained for 
VSNL1.  
 
3.6 Protein Isolation, Immunoprecipitation and Western Blotting (I, III) 
 
Proteins were isolated from embryonic kidneys using lysis buffer (1% Igepal CA-630, 
1% Triton-X, 10% glycerol, 2 mM EDTA/TBS pH 7.5), supplemented with 1 mM 
Na3VO4 and  Complete,  Mini  Protease  Inhibitor  Cocktail  Tablet  (Roche).  Tissue  was  
homogenized by mechanical disruption in lysis buffer on ice for 30-45 minutes. The 
supernatant was collected after centrifugation of the cell debris. Before 
immunoprecipitation (IP), 30 ?l of the supernatant was used as control in SDS-PAGE. The 
rest of the total lysate of 25-30 E14.5 kidneys was precleared in solubilization buffer and 
25 ?l Streptavidine beads (Cell Signaling) and the IP was done according to the 
manufacturer’s instructions using the anti-mouse PlexinB2 biotinilated antibody 
(eBioscience). Proteins were eluted with Laemmli sample buffer for 5 minutes at 100°C 
and loaded into the gel.  
Subconfluent mIMCD3 cells transiently transfected for 48 hours with an empty 
expression plasmid pCAb-IRES-EGFPm (Mock) or Vsnl1-expressing plasmid (pCAb-
Vsnl1-IRES-EGFPm) were harvested and then stimulated with Wnt3A- conditioned or 
Wnt3A- control medium for 2 hours. (Robinson et al., 2006). Cells were lyzed and 
analyzed by Western blots as described (Lindahl et al., 2001). The blots were probed with 
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the antibodies indicated in article III and developed with ECL reagents according to 
manufacturer’s instructions (Amersham Biosciences).  
 
3.7 Fluo4 Staining (I) 
 
UBs grown in Matrigel were depleted from the matrix by frequent washes in Hanks' 
balanced salt solution (HBSS; Invitrogen) and resuspended in HBSS supplemented with 
25 mM HEPES buffer (Invitrogen) containing Fluo-4 NW (Fluo4 NW Calcium Assay 
Kit). UB cultures were incubated at 37°C for 30 minutes and then at room temperature for 
additional 30 minutes and then cleared in HBSS. The samples were analyzed with Zeiss 
Axioplan II microscope with epifluorescence and photographed.  
 
3.8 Apoptosis and proliferation assays (III) 
 
Apoptosis in embryonic kidneys E12.5 kidney sections was analyzed by the indirect 
terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) method 
according to manufacturer’s instructions. The sections were mounted with Vectashield 
containing DAPI to visualize the nuclei. The level of apoptosis was measured as the 
proportion  of  the  TUNEL-positive  area  with  the  total  area  or  the  kidney  sections.  Cell  
proliferation in the UB tips was quantified by bromodeoxyuridine (BrdU; Amersham, GE 
Healthcare) incorporation. Pregnant females were injected intraperitoneally with BrdU and 
the embryos were harvested 4 hours later. E12 to E14 kidneys were dissected, fixed in 4% 
PFA, and embedded in paraffin. The sections were mounted by Vectashield containing 
DAPI. 
The number of BrdU-positive cells in the tips of the ureteric epithelium was compared 
with the total number of tip cells. 
  
3.9  Anti-PlexinB2 Antibody and Recombinant SEMA4C (III) 
 
A polyclonal antibody recognizing murine PlexinB2 peptide (1572-
EDSQQDLPGERHALLEEENR-1591) was raised in rabbits and affinity purified 
(Washington Biotechnology, Inc.). Soluble, recombinant Sema4C was a gift of Dr. Steven 
Strittmatter, Yale University. 
 
3.10  Cell Culture, DNA Reagents, and Luciferase Assay 
 
The mIMCD3 (mouse inner medullary collecting duct) cell line (ATCC, CRL-2123) 
was grown in DMEM supplemented with 10% FBS, 2 mM L-glutamine, 100 units/ml 
streptomycin, and 100 units/ml penicillin. TCF/LEF luciferase reporter constructs 
(TOPflash and FOPflash) (Upstate Biotechnology), pCAb-IRES-EGFPm empty vector (a 
gift from Jonathan Gilthorpe), and pCAb-IRES-Vsnl1-EGFPm expressing vectors were 
used for transient transfections which were performed using Lipofectamine Plus reagent 
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(Invitrogen). Each co-transfection was done in triplicates in 24-well plates, and each 
experiment was performed three times. Transfected cells were starved for 12 hours and 
stimulated with Wnt3A- conditioned medium versus control medium for 2 hours and the 
luciferase activity was detected by Luciferase Assay System (Promega, Madison, WI). 
Reporter activity was expressed as a ratio of luciferase to protein quantification. The 
statistical analyses were done by T test. 
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4 RESULTS AND DISCUSSION 
 
 
4.1 Microarray Analysis of GDNF Regulated Genes in the WD (I)  
 
Previous genome-wide studies aiming at discovery of novel genes in kidney 
development have either compared the gene expression profiles in whole and/or 
microdissected subdomains of the rodent kidneys, UB tip versus stalk versus MM, or have 
analyzed differentially expressed genes at various stages of kidney development (Stuart et 
al., 2001; Schwab et al., 2003; Stuart et al., 2003; Schmidt-Ott et al., 2005; Tsigelny et al., 
2008). More recently, new genes up-regulated by GDNF signaling have been identified by 
genome-wide analysis of isolated UBs cultured in matrigel with or without GDNF (Lu et 
al., 2009). 
To search for GDNF early responsive genes, we adopted an alternative approach. 
E10.5 halves of urogenital blocks, including the gonadal ridge, mesonephros, WD and 
MM, were cultured with exogenous GDNF (50ng/ml) for 16 hours. The contralateral half 
of  the  urogenital  block  of  the  same  embryo  served  as  a  control  and  was  grown  without  
exogenous GNDF. The 16 hours time point was chosen because it is just prior to any 
morphological signs of ectopic ureteric bud formation from the WD. From the cultured 
urogenital blocks, a segment of WD with a minimal amount of attached mesenchymal 
cells between mesonephric and metanephric rudiments was microdissected for microarray 
analysis.  
Using a p-value cutoff of 0.05, 1102 differentially expressed genes were identified in 
four replica sample pairs. As the number of expected false positives at this threshold was 
too high, we used the fold change of 1.890, corresponding to the fold- change of the 
GDNF co-receptor (Gfr?1), as an additional cutoff. This resulted in a list of 69 up-
regulated and 50 down-regulated candidate genes. Among the up-regulated genes, for 
some of the genes, the ureteric epithelium specific expression was already described 
(Crlf1, Ros1, Calb1, Arg2, Aldh1a7 and Aldh1a3), other genes were found in previous 
microarray studies (Mtmr7, Neu1, Tuba4, Vsnl1), or had been identified as GDNF/Ret 
target genes in the UB (Ret, Spry1, Etv4, Wnt11) (Schwab et al., 2003; Schmidt-Ott et al., 
2005; Caruana et al., 2006; Schwab et al., 2006; Lu et al., 2009). 
The universal agreement of our microarray data with previous studies provided 
therefore an important measure of validation. To further validate the remaining 
uncharacterized GDNF candidate target genes in WD, we assayed their expression in 
E10.5 kidneys by ISH. As we were interested in genes up-regulated by GDNF in the 
ureteric bud, we focused on genes expressed in the ureteric epithelium and identified six 
new genes with an exclusive epithelial expression.  
However, these results do not provide a direct evidence of their regulation upon GDNF 
in the ureteric bud. As another criteria of validation, we next used Gdnf- null allele and 
wild type kidney explants grown with exogenous GDNF to identify the genes, whose 
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expression is specifically altered by GDNF/Ret signaling. Most of the GDNF upregulated 
genes showed normal levels of expression in the Gdnf–null allele E11 kidney rudiments, 
and were upregulated in the ectopic buds formed along the WD. Only two genes, Visinin 
like-1 (Vsnl1) and Plakophilin 2 (Pkp2) were lacking or downregulated in Gdnf null allele 
kidneys, and their transcripts were restored by exogenous GDNF in explants culture. 
These genes were therefore selected for further analysis. 
 
4.2 Plakofilin2 in Kidney Development (unpublished data) 
 
Plakophilin2 gene, encoding for Pkp2 protein, belongs to a subfamily of armadillo-
repeat  proteins  that  are  found  in  desmosomes,  where  they  are  acting  as  scaffolding  
proteins (Klymkowsky, 1999).  Pkp2- null allele mice exhibit alterations in heart 
morphogenesis and die around E11 (Grossmann et al., 2004).  
Among the four members of the Pkp subfamily, we identified by ISH only three in the 
developing kidney. Pkp2, Pkp3 and Pkp4 are expressed in the ureteric epithelium, and in 
addition Pkp4 was detected also in the MM (data not shown). Pkp1 was not expressed in 
the developing methanephros (data not shown). Pkp2 was enriched in the ureteric tips at 
E11 and in the supernumerary buds induced with GDNF, and lower levels could be also 
detected  in  the  WD  (Figure  5A,B).  Pkp2 expression was downregulated in Gdnf- null 
urogenital blocks and its expression was again up-regulated in the rescued UB of E11 
Gdnf- null kidneys as well as in the ectopic buds induced by exogenous GDNF (Figure 
5C,D), which suggested that Pkp2 could be a GDNF target in the ureteric epithelium. 
 
Figure 5. Pkp2 expression in early kidney development. 
ISH shows Pkp2 expression in the UB tips and WD in E11 
kidneys  (A)  and  in  the  ectopic  buds  in  the  WD  in  wild  
type kidney rudiments grown for 48 h with 50 ng/ml of 
GDNF (B). Pkp2 is downregulated in Gdnf-/- kidneys and 
rescued in Gndf-/- kidneys grown with GDNF for 48 h.  
 
The Pkp2- null allele mice were available 
(Grossmann et al., 2004) and their kidneys were 
further analyzed. Because these mice show high 
embryonic lethality soon after E12, we were able 
to analyze early kidney rudiments of Pkp2- null 
allele mice at E10.5 to E12.  
Pkp2 -/- kidney explants dissected at E11 did 
not undergo UB branching when grown in culture for 1 to 3 days, but they responded to 
GDNF by supernumerary budding from WD (Figure 6A-D). The mesonephric tubules 
developed normally (data not shown). Interestingly, the buds formed showed some 
branching (Figure 6D), which does not normally take place in ectopic UBs derived from 
the WD upon GDNF induction (Figure 6C). It may be possible that these buds also 
represent true UBs with abnormal morphology and branching patterns forming multiple 
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ureters at the site of the MM. This suggests that also some inhibitory mechanisms 
normally restricting the UB formation to a single location would not be functional in Pkp2 
null allele kidneys. However, the response of Pkp2 null allele urogenital blocks to GDNF 
by supernumerary budding shows that Pkp2 is not causing UB formation from the WD per 
se. The high embryonic lethality of Pkp2- null allele mice at E10.5 to E12 may cause 
secondary damage in the dissected kidney rudiments, not only disrupting the UB, but also 
the MM. Therefore, the conditional deletion of Pkp2 is needed to corroborate the role of 
Pkp2 in more detail in kidney morphogenesis. 
 
Figure 6. Pkp2-/- kidneys respond to GDNF. 
Double immunostaining with antibodies to pan-
cytokeratin (red) and brush border epitopes (green) 
of E10.5 wild type (A) and Pkp2-/- kidneys (B) 
cultured for 48h. C,D show wild type and Pkp2-/- 
kidneys grown with GDNF for 48 h. 
 
 
 
 
 
 
 
 
4.3 VSNL1 Expression in Kidney Development (I) 
 
Vsnl1 has been previously identified in another mouse kidney microarray study, as an 
enriched gene in the UB at E11.5, however its spatial expression in the kidney has not 
been addressed (Schwab et al., 2003). Therefore, VSNL1 protein and mRNA expression in 
renal differentiation were first analyzed. In early development, both the Vsnl1 mRNA and 
protein were expressed in the same cells as the GDNF receptors, Ret and Gfr?1.  It  was  
detected first throughout the WD, prior to ureteric budding and then downregulated in the 
WD and the trunks of the UB branches, but maintained in the tips. Contrary to the 
transcript,  low  levels  of  the  VSNL1  protein  could  also  be  detected  in  the  WD  and  
medullary stalks. 
In contrast to other UB tip markers (Ret and Wnt11), or to other calcium binding 
molecules expressed in the UB tip epithelium such as Calbindin1 (Davies, 1994), Vsnl1 
expression has declined by E16, when only few cells in the UB tip expressed the transcript 
and protein. Both, branching morphogenesis and nephrogenesis continue to the first 
postnatal days in mouse, suggesting that Vsnl1 is not needed for the late stages of kidney 
development. 
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4.4 VSNL1 in Ureteric Budding and Branching (I) 
 
VSNL1 expression was next analyzed in tissue culture and mice with genetically 
disrupted UB branching. Similarly to the transcript, VSNL1 protein was upregulated in the 
supernumerary buds induced along the WD by exogenous GDNF, and it was lacking in 
the E11 Gdnf-/- mouse kidney rudiments.  
The protein expression was restored after 36 hours incubation with GDNF, whereas 
about 20 hours was needed to detect the Vsnl1 transcripts, which fits well with our original 
cut-off time of 16 hours in the microarray assay. This may indicate a slow turnover of this 
protein, but currently no data are available on its stability. Unlike in Gdnf- null allele 
kidney rudiments, VSNL1 was expressed at low levels in E11 Ret- deficient kidneys. This 
cannot be attributed to a slow turnover, but rather than to redundancy with other signals in 
regulation of UB branching. In Wnt11-/- mice, which display only a mild defect in ureteric 
branching (Majumdar et al., 2003), VSNL1 protein was maintained at the tips of the UBs 
at the levels comparable to wild type kidneys, suggesting that VSNL1 is not regulated by 
non-canonical Wnt signaling. Overall, the VSNL1 expression levels seem to correlate with 
the degree of ureteric branching.  
Besides GDNF signaling, there is in vitro and in vivo evidence of other signaling 
pathways, redundant with GDNF in renal branching morphogenesis (Michos et al., 2010). 
FGF7 in combination with Follistatin, an inhibitor of Activin A, is able to induce in vitro 
ureteric budding, independently of GDNF (Maeshima et al., 2007).  
When wild type, Gdnf- and Ret-  null  allele  kidney  explants  were  exposed  to  a  
combination of FGF7 and Follistatin, VSNL1 was upregulated in the supernumerary buds 
formed  along  the  WD,  irrespective  of  the  genotype.  These  results  show  that  VSNL1  
characterizes the tip of the UB, irrespective of the inducer. 
 
4.5 Elevated Intracellular Ca2+ in the UB Tips (I) 
 
In the UB tips, VSNL1 is expressed at different intensity from cell to cell. The reason 
for this mosaicism is not understood. However, it is well established that upon binding 
calcium ions, VSNL1 undergoes a calcium-myristoyl switch, the protein interacts with cell 
membranes and activates different signals (Zozulya and Stryer, 1992). 
When the UBs are placed in GDNF containing matrigel, they branch, even when 
isolated from the MM (Qiao et al., 1999a). The newly formed tips of the UB cultures, 
where VSNL1 is predominantly expressed displayed a high calcium activity, as visualized 
by Fluo4 staining. This correlation remains to be elucidated by genetic models. 
Furthermore, the receptor tyrosine kinase- Ret is unique among receptor tyrosine kinases 
for the presence of the cadherin-like motif with Ca2+- binding sites in the extracellular 
domain (Anders et al., 2001) and the tips of the UB contain the highest levels of Ret 
activity (Shakya et al., 2005; Chi et al., 2009). GDNF binding to Ret and its 
phosphorylation  as  well  as  morphological  differentiation  of  the  neuroblastoma  cells  are  
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dependent on Ca2+, suggesting that Ca2+ ions  are  essential  components  of  the  signal  
transduction through Ret in these cells (Nozaki et al., 1998).  
These results together with our in situ observations suggest that VSNL1 up-regulation 
upon GDNF/Ret signaling in the tips of the UBs may be dependent on Ca2+. VSNL1 
promotes cAMP signaling in a Ca2+- dependent manner in several cell types, but not in the 
olfactory neurons, where it has opposite effects (Boekhoff et al., 1997; Braunewell and 
Klein-Szanto, 2009). On the other hand, increased activity of a cAMP effector protein 
kinase A (PKA), results in a complete inhibition of UB outgrowth from the WD. This is 
reversible, as when the PKA levels are diminished, the ureteric budding takes place, but 
this process is dependent of GDNF (Tee et al., 2010). VSNL1 might modulate the PKA 
activity in the developing kidney, as it does in the squamous carcinoma cells (Gonzalez 
Guerrico et al., 2005), but further in vivo and in vitro evidences are needed to reveal the 
role of VSNL1 in this context, in the kidney. 
To  explain  the  unique  pattern  of  VSNL1  in  the  UB  tips,  we  correlated  it  with  other  
molecules displaying an uneven or a similar expression pattern in these cells.  
Two possible explanations have been raised. There might be two molecularly and/or 
functionally  different  cell  types  in  the  UB  tip  or  the  differential  expression  may  reflect  
VSNL1- positive or VSNL1- negative cells being in different phases of cell cycle 
depending on their VSNL1 expression. We studied these possibilities further. 
The activation of ERK/MAPK pathway, by GDNF/Ret signaling is calcium dependent, 
and Ca2+ is essential for cell proliferation (Nozaki et al., 1998; van Weering et al., 1998). 
Based on co-labeling studies, we did not find a correlation between VSNL1 and the 
diphosphorylated form of Erk1/2 (dp-ERK1/2), an established indicator of Ret signaling in 
the UB tips (Chi et al., 2009), as dp-ERK1/2- positive cells contained variable levels of 
VSNL1. 
We then analyzed the association of VSNL1 mosaic expression in the UB tips with cell 
cycle progression. Double labeling with antibodies for VSNL1 and different cell cycle 
markers identified little VSNL1 expression during S phase, as cells positive for PCNA 
(proliferation cell nuclear antigen) contained low levels of VSNL1. VSNL1 intensity 
increased towards the M phase, as Phist3 positive cells contained elevated VSNL1 levels. 
However,  few  mitotic  spindle-  positive  cells  contained  low  levels  of  VSNL1.  However,  
further studies using tagged constructs are needed to clarify the correlation of VSNL1 
expression levels with cell cycle progression. 
 
4.6 VSNL1 - ?-Catenin in UB epithelium (I) 
 
VSNL1 is a calcium sensor protein, and its activity is mostly dependent on Ca2+ 
(Braunewell and Klein-Szanto, 2009). Increased levels of intracellular Ca2+ and activated 
calcium sensors antagonize the canonical ?-catenin activity in the same cells (Maye et al., 
2004; Schneider et al., 2008).  
We therefore explored the possible antagonism between VSNL1 and ?-catenin in the 
UB tip cells. Several reporter mouse lines have been created to identify the expression 
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sites of activated Lef/TCF and presumably ?-catenin during embryogenesis (Jho et al., 
2002; Maretto et al., 2003; Iglesias et al., 2007). One of these reporters, BAT-gal mouse 
line that expresses ?-galactosidase under a Wnt/?-catenin responsive promoter, is 
detecting canonical ?-catenin activity exclusively in the ureteric epithelium, with a mosaic 
labeling pattern (Maretto et al., 2003). 
In BAT-gal kidney rudiments, the X-gal staining was gradually decreasing towards the 
UB tips, and was mutually exclusive to VSNL1, suggesting that high Ca2+ may antagonize 
Wnt signaling also in the UB tips. This prompted us to study further ?-catenin and VSNL1 
antagonism or positive interaction by using an in vitro model, the mIMCD3 cell line. The 
cells were transiently co-transfected with the TCF reporter TOPFLASH, as a measurement 
of ?-catenin activity in the nucleus and the full-length murine Vsnl1 cDNA or control 
vector. The cells were cultured with or without Wnt3A conditioned medium. Wnt3A is a 
canonical Wnt ligand that activates ?-catenin (Oloumi et al., 2006). By measuring the 
Luciferase activity, we observed a reduction in TCF activity in Vsnl1-transfected cells 
cultured with control and Wnt3A conditioned medium, when compared with mock 
transfected cells. Thus, VSNL1 compromises ?-catenin stabilization in the mIMCD3 cells.  
This begged the question, as to which level Vsnl1 might  be  driving  its  effect.  In  
accordance with pancreatic ?-cells (Dai et al., 2006), we found that VSNL1 up-regulated 
GSK-3? expression, suggesting that in the mIMCD3 cells, VSNL1 promotes ?-catenin 
degradation by controlling the levels of GSK-3?, a key inhibitor of ?-catenin stability. 
However, the effect of VSNL1 on ?-catenin stability, as many other functions of VSNL1, 
might by cell type specific. Therefore more data about this possibility in different kidney 
models is required.  
To address the possible counterplay regulation of VSNL1 and ?-catenin in vivo, we 
analyzed VSNL1 expression in genetic models with ?-catenin loss (?-catub) (Bridgewater 
et al., 2008; Marose et al., 2008) or gain of function (?-catGOF-UB) mutations in the ureteric 
epithelium (Bridgewater et al., 2011). 
Interestingly, both, ?-catGOF-UB and ?-catub-/- kidneys demonstrated loss of Vsnl1 
expression in the UB. These data show that the dosage of ?-catenin is important to sustain 
the expression of VSNL1 in the UB tips. In ?-catub-/- kidneys, genes characterizing the UB 
tips, such as Emx2, Lim1 and Pax2 transcription factors and consequently Ret and Wnt11, 
are all downregulated (Marose et al., 2008; Bridgewater and Rosenblum, 2009). 
Therefore, loss of VSNL1 may actually reflect an absence of tip identity in this genetic 
model. In ?-catGOF-UB kidneys, few cells are still expressing VSNL1 in the UB, suggesting 
that VSNL1 expression is not completely dependent on activated ?-catenin in the ureteric 
epithelium. 
Taken together, VSNL1 is a novel marker for UB tips in embryonic kidneys. The 
mosaic pattern of VSNL1 suggests that the tip has two molecularly different cell 
populations. It is tempting to speculate that these cells could respond differently to 
mesenchyme-derived inductive signals and even show differential developmental fates. 
The VSNL1- positive/low ??-catenin cells might be the real tip cells that continue 
branching, while the VSNL1- negative/high ?-catenin cell may represent stalk identity. 
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4.7 VSNL1 Expression During Mouse Embryogenesis (II) 
 
We next analyzed other expression domains of Vsnl1 mRNA and protein during 
embryogenesis. Previous studies have been focused on VSNL1 expression in the CNS, 
since VSNLs proteins belong to NCS, which for many years were thought to play a role 
primarily, if not exclusively in the brain. Moreover, the mouse has been seldom analyzed; 
most data are from other animal models as chick or rat, and predominantly adult tissues.  
We used both ISH with IHC to map the expression of Vsnl1 transcript and the protein, 
in the developing mouse with novel histological details in time and space manner.  
During embryogenesis, VSNL1 was identified in additional organs derived from the 
IM, namely in the genital ridge and in the adrenal cortex. However, the earliest organ with 
Vsnl1 expression was the heart primordium, which originates from splachnic mesoderm of 
the LPM. In addition to expression in mesoderm-derived tissues, VSNL1 was detected in 
the mouse embryonic brain and ventral spinal cord neurons similarly to the expression 
pattern in the gerbils (Ren et al., 2010). Immunoreactivity was also seen in cochlea, 
salivary ducts, taste and thyroid buds, tongue and the superior palate epithelium and in the 
trigeminal ganglia neurons. 
In accordance with other studies (Bastianelli et al., 1995; De Raad et al., 1995; 
Boekhoff et al., 1997; Mahloogi et al., 2003), VSNL1 was detected in the intrafollicular 
epidermis of the skin, in the squamous epithelium of the esophagus, and in the olfactory 
epithelium and olfactory neurons. 
In the eye, VSNL1 displayed an expression pattern similar to rat, bovine and chick retina, 
suggesting a well conserved pattern of expression in higher vertebrates (De Raad et al., 
1995). However, in contrast to Western blot analysis of E19 and adult rats (Gierke et al., 
2004), we did not detect VSNL1 in liver, pancreas, stomach or colon. This might be due to 
species differences, or VSNL1 expression becomes more apparent during adulthood at 
these specific locations. 
 
4.8 VSNL1 Marks the Developing Venous Pole Myocardium (II) 
 
We further analyzed the mouse Vsnl1 expression in cardiac primordium by ISH. Vsnl1 
became first evident soon after gastrulation, when the transcripts characterized the 
precardiac mesoderm. As the edges of the cardiogenic plates started to fuse, Vsnl1 was 
symmetrically expressed in both cardiac primordia with a pattern resembling that of 
Serca2a (Sarcoplasmic reticulum calcium ATPase2a) mRNA at this stage (Moorman et 
al., 1995). The Serca2a gene, encoding for a calcium pump protein, responsible for the 
calcium uptake into the sarcoplasmic reticulum of the cardiac muscle is one of the earliest 
markers for the cardiogenic plate (Fabiato and Fabiato, 1979; Brandl et al., 1987; 
Moorman et al., 1995).  
As the tubular heart forms, the first myocardial contractions take place, although 
circulation does not begin until the tube has formed and begins to loop (Evans et al., 
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2011). Contraction of the heart requires a specific set of proteins forming the contractile 
apparatus (sarcomere), including myosin heavy chain (MHC), myosin light chain (MLC), 
actin, troponin/tropomyosin, and various intermediate filament isoforms (Schiaffino and 
Reggiani, 1996). In general, the expression pattern of sarcomeric genes in the primitive 
myocardium resemble that of Vsnl1. As a calcium binding protein, VSNL1 might interact 
with Serca2a in calcium signaling. Also, its implications in the cytoskeleton arhitecture 
deserves further studies. 
When a single heart tube has formed in an A/P arrangement, Vsnl1 expression was 
seen in a subset of cardiomyocytes in the most caudal (posterior, inflow) region, 
containing the precursors of the developing venous tributaries of the embryo, the sinus 
venosus and the atria. No Vsnl1 transcripts were detected in the cranial (anterior, outflow) 
end of the tube having the precursors of the left ventricle and arterial system.  
Based on the expression of atrial myosin heavy chain (AMHC1) in chicken, it has been 
suggested that cells forming the atria are already distinguishable in the posterior region of 
the heart tube, earlier than the ventricular myosin (VMHC1) is expressed (Yutzey et al., 
1994). The spatial restriction of Vsnl1 to the posterior region of the murine heart tube 
suggests that the atrial identity is acquired earlier than that of the ventricles, although in 
the mammalian heart tube most of the genes are expressed in a gradient fashion and only 
after looping there are clearly defined compartments with specific gene expression 
patterns. Contractile proteins such as ?-MHC and MLC2a, cardiac actin and cardiac 
troponin are expressed in an A/P gradient in the tubular heart, as well as Serca2 (Franco et 
al., 2002), overlapping Vsnl1 expression in the caudal myocardium. 
The linear heart tube undergoes right-side looping and the newly formed myocardium 
is added to both ends of the heart tube. An array of distinct compartments become now 
visible: OT, ventricles, AVC, atrium and sinus venosus. In the looped heart, Vsnl1 
expression was maintained in the sinus venosus giving rise to the systemic drainage and in 
the pulmonary venous return, as well as in the common atrium, although Vsnl1 was more 
prominent at the venous pole myocardium. This pattern of expression was maintained 
during later stages of heart development. The common atria is divided into right and left 
components by the primary atrial septum, concomitant with the formation of the lung buds 
in the mediastinal mesenchyme, and the pulmonary vein (Soufan et al., 2004; Sizarov et 
al., 2010). The primordium of the pulmonary vein (pulmonary pit) is surrounded by atrial 
myocardium that was immunoreactive for VSNL1. Later in development, VSNL1 
expression becomes confined to the myocardium of both, the extrapulmonary and 
intrapulmonary veins. 
There is a large variation in opinions, concerning the cellular origin of the systemic 
and pulmonary myocardial venous returns (Christoffels et al., 2006; Mommersteeg et al., 
2007; Sizarov et al., 2010). 
Studies in different species reveal distinct lineages and molecular signatures of the 
systemic and pulmonary (mediastinal) myocardium, indicating an evolutionary 
conservation of the genetic program for the formation of these compartments at the venous 
pole.  Moreover,  the  pulmonary  vein  and  the  atrial  myocardium  seem  to  share  the  same  
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molecular phenotype. In the mouse, Nkx2-5 and its target gene, the conducting gap-
junctional Connexin40, (Cx40) are exclusively expressed in the atria and in the pulmonary 
myocardium, but not in the systemic venous return, which in contrast expresses Tbx18 and 
the essential pacemaker channel Hcn4 (Garcia-Frigola et al., 2003; Soufan et al., 2004; 
Christoffels et al., 2006; Mommersteeg et al., 2010). Also Pitx2 seems to be requiered for 
atrial identity on the left side of the heart and for the formation and identity of the 
pulmonary myocardium (Mommersteeg et al., 2007). 
However, Vsnl1 is observed in both systemic and pulmonary drainage at the venous 
pole of the heart, and can not distinguish between these two different cell populations. 
Atria and ventricles differ also in their contractile and electrophysiological 
characteristics, so that the atrial segments have rapid contractions and long diastole, 
whereas the ventricles display long-lasting contractions (Moorman et al., 1995). How 
Vsnl1 expression is maintained specifically in the atria during embryonic development and 
what is its function remains to be solved.  
We can conclude that the inflow tract and atria characterized by VSNL1 contract 
rapidly (short lasting) owing to the expression of the fast myosin isoform, whereas the 
downstream compartments  (AVC,  ventricle,  and  OT)  contract  slowly  (long  lasting),  and  
are lacking VSNL1 expression. Serca2a/PLB system seems to regulate the contraction–
relaxation cycle of the sarcomeric apparatus by modulating the changes in the intracellular 
concentration of Ca2+, and a greater capacity for the atria and venous pole to clear calcium 
during longer diastole, then the downstream compartments in the embryonic heart 
(Moorman et al., 1995; Moorman et al., 2000). Also troponin complexes are involved in 
the regulation of the cardiac muscles contraction by their interaction with Ca2+ ions.  
It might be possible that VSNL1 would play a similar role, as its localization and 
hence its functions are both dependent on intracellular concentration of Ca2+. 
As the development continues, Vsnl1 mRNA and protein are detected in additional 
myocardial domains, suggesting that Vsnl1 positive cells are acquired during heart 
development and then maintained in all myocardial components at the venous pole during 
further development. Based on differential gene expression patterns and transgenic mouse 
models four different myocardial transcriptional domains have been identified at the 
venous pole of the heart: (1) the atrioventricular canal-derived (AVC); (2) the atrial 
appendages; (3) the caval vein myocardium and the venous valve leaflets and (4) the 
mediastinal myocardium, consisting in the pulmonary vein myocardium and the atrial 
septa (Franco et al., 2000). VSNL1 overlaps the expression of several myosins isoforms, 
but only partially; the expression of MCL3F mRNA in the atrial appendages and 
myocardium surrounding the caval veins, the expression of MLC2V in caval veins 
myocardium and lower rim of the atrial appendages (consistent with its expression in the 
AVC),  and  the  expression  of  ?-MHC, MLC1A, MLC2A in all venous myocardial 
components (Franco et al., 2000).  
In addition to contractile apparatus, other genes mark all myocardial components at the 
venous pole, such as Serca2, while the gene encoding for atrial natriuretic factor (ANF) is 
detected only in the atrial appendages (Franco et al., 2000), or the gene encoding for 
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transcription factor imprinting leftness, Pitx2 identifies only the left components of each 
of  the  four  transcriptional  domains  that  form  the  venous  pole  of  the  heart  (Zeller  et  al.,  
1987). 
Vsnl1 was first identified in the Tbx5 (T-box transcription factor) hypomorphic hearts, 
where a reduction in Vsnl1 transcripts in the atrial myocardium has been observed (Mori et 
al., 2006). Tbx5 transcription factor is involved in cardiac chamber specification and 
morphogenesis and its expression overlaps with that of Vsnl1 during early heart 
development, whereas later in development, Tbx5 expression pattern is extended to the 
atria and left ventricle (Bruneau et al., 2001). Whether Vsnl1 is specifically regulated by 
Tbx5 in early heart development or rather its downregulation is a secundary event should 
be more thoroughly investigated.  
In the developing kidney, the expression of both the transcript and the protein 
decreased by E16 from the UB epithelium. To identify if loss of VSNL1 expression is a 
generalized phenomenon in late embryogenesis, VSNL1 expression was examined more 
in detail at late stages of heart development. 
During E16-E18 and also in the first postanatal days (P1-P7), we observed the same 
restricted expression of VSNL1 in all myocardial domains at the venous pole of the heart. 
Thus, downregulation of VSNL1 at E16 is not a general phenomenon, it rather seems to be 
organ specific. 
 
4.9 VSNL1 Expression in the Adult Heart (II) 
 
An expansion of the VSNL1 expression domain to the ventricles is observed soon after 
first week of postnatal life (data not shown), VSNL1 is then evenly distributed in both 
atria  and  ventricles  and  this  pattern  is  maintained  to  adulthood.  These  results  are  in  
accordance with a previous study, which identified Vsnl1 by RT-PCR and Western blot 
analyses  in  all  cardiac  chambers  of  adult  rat  and  human  hearts  (Buttgereit  et  al.,  2010),  
suggesting an evolutionary conserved genetic program for the maintenance of Vsnl1 
expression in the heart.  
However, VSNL1’s greater expression in the myocardium of the caval and pulmonary 
veins, then in the chamber’s myocardium is maintained also in the adult heart. A similar 
pattern of expression was observed for the murine ?-MHC. Its levels gradually increased 
from atria in the fetal heart to all cardiac chambers of the adult heart (Franco et al., 2002; 
Haddad et al., 2008). 
 
4.10  VSNL1 - a New Cardyomyocite Marker in the Mouse Heart (II) 
 
The heart is formed from cardiogenic multipotent progenitor cells that give rise to the 
major lineages of the heart: cardiomyocytes, smooth muscles cells and endothelial cells. 
To investigate the precise cellular distribution of VSNL1 in the heart, co-immunolabeling 
for VSNL1 and cardiac lineage tracers: a cardiomyocyte marker- cardiac troponin (CT3), 
endothelial cell marker- endomucin and a smooth muscle marker- SM22?, was carried out 
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on E14 and E16 mouse heart sections. As determined with the localization of each of the 
well established markers in the heart, VSNL1 was identified exclusively in atrial 
cardiomyocytes during embryogenesis, and also in the ventricular cardiomyocytes in the 
adult heart.  
VSNL1 also served as a specific marker for the cardiomyocyte- derived structures in 
the systemic and pulmonary circulation. Despite the well characterized spatial and 
temporal expression, the molecular and cellular mechanisms of VSNL1 function in the 
developing heart remain largely obscure and should be further addressed. 
 
4.11  PlexinB2 is Necessary for the Ureteric Branching (III) 
 
Plexins interact and modulate the receptor tyrosine kinase- Met signaling in several 
model systems (Giordano et al., 2002). In the same manner, GDNF, in the absence of Ret, 
promotes tubulogenesis throught Met (Popsueva et al., 2003), suggesting a possible 
crosstalk between the two pathways in kidney morphogenesis. 
In addition to other organs, PlexinB1 and PlexinB2 expression patterns are mostly 
overlapping in the developing kidney (Perala et al., 2005; Fazzari et al., 2007). After 
midgestation, PlexinB2 is identified in the ureteric epithelium, nephrogenic tubules, 
glomeruli and cap condensates, as showed by PlexinB2 antibody staining that 
recapitulates the previously characterized Plxnb2 mRNA expression pattern (Perala et al., 
2005). 
The Plxnb1- null allele mice show a temporarily increased rate of ureteric branching 
during embryogenesis, but normal size of kidneys at birth (Fazzari et al., 2007), which 
might be due to redundant functions with Plxnb2. It has been suggested that Sema4D is 
the functional ligand of PlexinB1 in the developing kidney (Korostylev et al., 2008). We 
therefore analyzed the kidney morphogenesis in Plxnb2- null allele mice (Friedel et al., 
2007).  
By  E10.5,  the  UB  outgrowth  from  the  WD  occurred  and  the  bud  underwent  its  first  
round of branching in a normal pattern, showing that the Plxnb2 deficient ureteric 
epithelium is able to bud and initiate branching, with no delay in the formation of the UB. 
Starting with E12, the Plxnb2-/- kidneys were smaller than the correspondent heterozygous 
(Plxnb2+/-) or wild type kidneys. Moreover, a slight difference in size was observed also 
between Plxnb2+/- and wild type kidneys, even though the overall size and developmental 
stage of the whole embryos were alike. By measuring the length along their longitudinal 
axis of the E12.5 kidneys, the Plxnb2-/- kidney rudiments were 25% shorter than their 
corresponding wild type littermates. 
However, morphologically, the Plxnb2-/- kidneys were normal at E15.5, as the 
histological analysis identified all different cell types forming the developing kidney. To 
identify the mechanism of reduced kidney size in Plxnb2-/- embryos, the expression of 
different markers for different structures in the developing kidney was analyzed. The 
mutant kidneys displayed normal expression pattern of stalk and tip markers of the 
ureteric epithelium, as well as the markers for MM, stroma and vasculature (Raldh2, Wt1, 
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Endomucin, Pax2, Vangl2, Wnt11, Sox9, Wnt9b, Foxd1, SMA), with patterns comparable 
to those in the wild type kidneys, suggesting normal renal differentiation, despite the 
smaller kidney size of the homozygous kidneys. 
Less branching of the ureteric epithelium in the Plxnb2-/- kidneys was already observed 
at E12, as visualized by an epithelium marker-pancytokeratin staining. By quantifying the 
number of the tips of the UB branches at E12.5, the Plxnb2-/- kidneys showed 40% 
(p<0.001) less UB tips, when compared with other genotypes. Thus, unlike the deletion of 
Plxnb1, the Plxnb2- null allele mice displayed decreased branching.  
The reduction in the UB branching might be caused by defective proliferation and/or 
apoptosis. Defective cell proliferation has already been determined in the developing 
nervous system of Plxnb2-/- embryos (Deng et al., 2007; Hirschberg et al., 2009). 
Therefore, we next measured cell proliferation by BrdU incorporation and observed a 
decrease in the proliferation rate in the Plxnb2-/- UB tips by 9% (p<0.05), when compared 
to wild type kidneys. There was no significant difference in the levels of apoptosis 
between distinct genotypes, suggesting that defective proliferation might cause reduction 
in ureteric branching.  
About 10% of the Plxnb2-/- embryos display unilateral or bilateral double ureters and 
kidneys, further suggesting defects in the control of primary budding. Similar branching 
defects have been found in several mice lacking negative regulators of GDNF/Ret 
signaling or controllers of ureteric budding site or the GDNF expression domain, such as 
Sprouty-1 (Chi et al., 2004; Basson et al., 2005), BMP4 (Miyazaki et al., 2000), 
Slit1/Robo2 (Grieshammer et al., 2004) and FoxC1 transcription factor (Kume et al., 
2000). To identify if any of the corresponding genes are responsible for the double ureter 
formation in the Plxnb2-/- embryos,  we  performed ISH and  observed  that  the  expression  
patterns of Gdnf, Ret, Pax2 and Spry1 were normal in Plxnb2-/- kidneys, leaving the 
explanation for the occasional double ureters unsolved.  
 
4.12  Plxnb2-/-  Impaired Branching is due to Defects in Ureteric Epithelium (III) 
 
We then asked whether the branching defects were due to a primary defect in the 
ureteric epithelium or were secondary, being caused by inappropriate mesenchymal 
signals. Isolated E12.5 UB epithelium depleted of mesenchyme was cultured in matrigel 
containing GDNF. The Plxnb2-/- UB was unable to respond, when exposed to GDNF 
alone, suggesting that PlexinB2 might modulate GDNF/Ret signaling. When the Plxnb2-/- 
UBs  were  grown  in  the  presence  of  FGF7/Follistatin,  or  when  these  factors  were  
combined with GDNF, the Plxnb2-/- UB response was comparable with that seen in wild 
type UB cultures. These results suggest that other factors present in the MM, perhaps 
working like FGF7 and Follistatin, improved the GDNF-response of the Plxnb2-/- ureteric 
epithelium. However, when whole Plxnb2-/- kidney rudiments were cultured with 
exogenous GDNF, the WD responded normally by supernumerary budding, suggesting 
that other factors required for the activation of Ret in the MM are responsible for 
correcting the defective branching seen in the isolated UBs from Plxnb2-/- mice. 
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When the E11.5 MM was depleted from epithelium and cultured alone in the presence 
of a GSK3 inhibitor (BIO -5’-bromoindirubin-3’-oxime) (Kuure et al., 2007), the MM 
underwent mesenchymal to epithelial transition, and nephrogenesis was normally induced, 
suggesting that the primary cause for defective branching is the intrinsic defect of the 
ureteric epithelium and that Plxnb2-/- is not necessary for the differentiation of the MM. 
 
4.13  PlexinB2 Interacts with Ret in the Ureteric Epithelium (III) 
 
As the Plxnb2-/- ureteric epithelium was unable to respond to GDNF, we analyzed the 
expression of previously identified GDNF downstream target genes in Plxnb2-/- kidney  
explants. All known GDNF regulated genes Vsnl1, Wnt11, Etv5, Myb, Etv4, Crlf1 and 
Cxcr4,  as  well  as  Gdnf and Gfr?1 transcripts were expressed in Plxnb2-/- at comparable 
levels to the wild type kidneys. However, changes in the transcription of these molecules 
cannot be excluded yet, as the mRNA transcript detected by ISH is only a semi-
quantitative method.  
The  PlexinB-  subfamily  interacts  and  activates  RTKs,  such  as  Met  and  ErbB2  
(Giordano et al., 2002; Swiercz et al., 2004; Deng et al., 2007) that are also expressed by 
the ureteric epithelium. On the other hand, GDNF was shown to modulate Met activity in 
vitro in the presence or absence of Ret (Popsueva et al., 2003). Staining of Plxnb2- null 
allele kidneys at multiple developmental stages with antibodies that label the activated 
forms of ErbB2 and Met revealed no differences in their phosphorylation state in the 
Plxnb2-/- kidney, suggesting that other RTKs might be affected. 
We finally analyzed whether PlexinB2 directly interacts with Ret. We 
immunoprecipitated E14.5 kidney lysates with an antibody against the extracellular 
domain of PlexinB2. The mature, glycosylated form of Ret (170 kDa) co-
immunoprecipitated with PlexinB2, suggesting that PlexinB2 interacts with Ret and by 
this interaction, it possible modulates Ret signaling and regulates the response of the 
ureteric epithelium to GDNF. Thus, we discovered Ret as a new interacting partner for 
PlexinB2.  However,  the  functional  significance  of  this  interaction  remains  to  be  
elucidated. 
PlexinB2 regulates actin cytoskeleton through PDZ-RhoGEF and LARG (Driessens et 
al., 2001; Aurandt et al., 2002; Swiercz et al., 2002) or R-Ras and integrins (Oinuma et al., 
2004; Oinuma et al., 2006). The actin cytoskeleton was therefore analyzed in Plxnb2-/- 
kidneys by phalloidin staining. We identified no changes in the organization of actin 
filaments in Plxnb2-/- kidney sections, suggesting that the ureteric branching defect is not a 
result of an improperly organized cytoskeleton. 
 
4.14  SEMA4C is the Ligand of PlexinB2 in the Developing Kidney (III) 
 
Sema4C is a preferred ligand for PlexinB2 (Deng et al., 2007), and in the developing 
kidney its expression overlaps that of PlexinB2. To determine if Sema4C is the ligand 
signaling through PlexinB2 in the metanephros, we cultured Plxnb2- null, heterozygote 
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and wild type E11.5 kidneys with and without the soluble Sema4C recombinant protein. 
Branching morphogenesis was stimulated by Sema4C in the wild type kidneys by 16%, 
but not in the null allele mice, suggesting that indeed Sema4C is the ligand of PlexinB2 in 
the kidney and it stimulates the UB branching morphogenesis. The effect was even higher 
in the Plxnb2+/- kidneys, where the UB tips number was increased with 40% (p<0.001), 
revealing the possible existence of a negative feedback loop regulating Sema4C-PlexinB2 
signaling in the kidney. 
On  the  other  hand,  also  Sema4D  binds  Plexin  B2,  albeit  at  lower  affinity  than  
PlexinB1 (Masuda et al., 2004; Deng et al., 2007). In the developing kidney, Sema4D 
ligand has been shown to signal through PlexinB1 (Korostylev et al., 2008). As PlexinB1 
and PlexinB2 exhibit an overlapping expression pattern in the developing kidney, and 
since they share common downstream signaling (Masuda et al., 2004; Swiercz et al., 2004; 
Deng et al., 2007), increased expression of PlexinB1 would explain the high response of 
Plxnb2+/- kidneys to Sema4C.  
Analyzing the expression of Plxnb1 in the Plxnb2-/- and Plxnb2+/- kidneys, we 
identified normal expression levels in these kidneys when compared with wild types, 
suggesting that PlexinB1 is not responsible for increased branching of Plxnb2+/- kidneys 
when stimulated with Sema4C.  
In spite of common downstream targets, PlexinB1 and PlexinB2 seem to exert 
opposite effects during kidney morphogenesis. The reason for this observation remains to 
be solved. 
 
4.15  PlexinB1 and B2 are not Essential for Kidney Development (III) 
 
To study further the existence of a possible redundancy between the PlexinB1 and 
PlexinB2 in the developing kidney, we crossed these mutant mouse lines to produce 
embryos lacking both genes. Double heterozygous Plxnb1+/-/Plxnb2+/- as  well  as  double  
null allele embyos with only one wild type allele (Plxnb1-/-/Plxnb2+/-) were viable and 
fertile, but the litter size was smaller than the corresponding controls. 
When both genes were deleted (Plxnb1-/- Plxnb2-/-), the embryos died around E10.5 
and we were able to analyze only one E12 embryo, out of 19 double homozygous 
embryos. This embryo had two kidneys, both hypoplastic with long ureteric branches and 
early differentiating mesenchyme, suggesting no redundancy in Plexins’ function during 
kidney development. The cause of early lethality in the double mutants has not been yet 
identified, but it would be tempting to presume that the early embryonic death would be 
due to a cardiovascular defect as both plexins have been associated with cardiac 
development. However, the conclusions are based on the analysis of a single double 
homozygous embryos. Expanded analysis would require that more embryos are collected 
and analyzed or that a tissue specific mouse model of PlexinB2 would be created.  
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5 CONCLUDING REMARKS AND FUTURE PROSPECTS 
 
 
The present study identified Pkp2 and Vsnl1 genes as novel early-responsive genes to 
GDNF in the ureteric epithelium, and in the same time brings new insights to elucidate the 
complexity of gene regulatory network activated by GDNF/Ret signaling that controls the 
ureteric bud branching morphogenesis.  
Analysis of the Pkp2 null allele mice revealed that Pkp2 is not necessary for the 
ureteric budding, as mutant kidney explants responded to GDNF by supernumerary 
budding, but these kidneys failed to undergo branching morphogenesis in vitro. However, 
the high embryonic lethality of Pkp2-/-deficient mice at E10.5 to E12 may cause secondary 
damage in the dissected kidney rudiments, therefore, the tissue specific deletion of Pkp2 is 
needed to corroborate the role of Pkp2 in more detail in kidney morphogenesis. 
VSNL1 characterized the tips of the ureteric bud, irrespective of the inducer and its 
levels of expression correlated with the degree of ureteric branching. The VSNL1 protein 
displayed a unique distribution in the ureteric bud, suggesting a heterogenous cell 
population in the UB tips, which could be correlated with neither Ret activity, nor with 
cell cycle progression. However, its expression was mutually exclusive with ?-catenin 
transcriptional activity in the ureteric epithelium and downregulated in both ?-catenin 
deficient and ?-catenin stabilized kidneys. In a cell model, VSNL1 antagonized ?-catenin 
stabilization by affecting GSK3? levels. These results suggest an antagonizing effect of 
VSNL1 and canonical Wnt signaling in the developing kidney and should be further 
investigated.  
VSNL1 has been previously studied in nervous system or in cancer. In the present 
study, Vsnl1 mRNA and protein were detected in all embryonic derivatives of the 
intermediate mesoderm; in addition to the kidneys, the gonads and adrenal cortex 
expressed high levels of VSNL1. Interestingly, Vsnl1 also turned out to be an early marker 
for cardiac anlagen and for the venous cardiac primordium derived from the lateral plate 
mesoderm, suggesting a role also in the development of other mesoderm-derived tissues. 
All myocardial cells that contribute to the remodeling of the venous pole of the heart 
are positive for Vsnl1. There are two possible explanations for this: cells expressing Vsnl1 
might be derived from a common lineage; or Vsnl1 mRNA transcription can be initiated in 
all cardiac cells and differential expression in contiguous regions of the developing heart 
would  be  due  to  gene  expression  up-  or  down-  regulated  by  regional  stimuli.  However,  
Vsnl1 gene induction may be a useful marker for cell lineages tracing during cardiac 
embryogenesis, as it is confined exclusively to cardiomyocytes. 
It  will  be  now  exciting  to  investigate  the  role  of  Vsnl1 during development using 
transgenic mouse models, interfering with endogenous Vsnl1 function by overexpression 
(knock-in) and/or deletion of the Vsnl1 gene (knock-out). 
Finally, we pinpointed PlexinB2 as a new modulator of ureteric branching. The 
Plxnb2-/- mice displayed hypoplastic kidneys and occasional unilateral duplication of the 
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ureter. We showed that GDNF receptor- Ret, is a novel interacting partner of PlexinB2 in 
the ureteric epithelium. This suggests a cross-talk between Sema4C-PlexinB2 and 
GDNF/Ret signaling pathways, possibly required for the normal patterning of the ureteric 
branching morphogenesis. However, a tissue targeted PlexinB2 mutant mouse would be 
necessary to study the function of PlexinB2 in the postnatal kidneys, as Plxnb2-/- mice 
show early embryonic lethality.  It would be also interesting to analyze more in detail the 
interaction between Ret and PlexinB2 and its importance in the kidney morphogenesis. 
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